Patent Grant
12134751
The present disclosure relates generally to coating compositions including active substances and methods of their use to facilitate removal of organic stains.
Many outdoor surfaces are subject to stain or insult from natural sources such as bird droppings, resins, and insect bodies. As a result, the resulting stain often leaves unpleasant marks on the surface deteriorating the appearance of the products.
Traditional self-cleaning coatings and surfaces are typically based on water rolling or sheeting to carry away inorganic materials. These show some level of effectiveness for removal of inorganic dirt, but are less effective for cleaning stains from biological sources, which consist of various types of organic polymers, fats, oils, and proteins each of which can deeply diffuse into the subsurface of coatings. Prior art approaches aim to reduce the deposition of stains on a surface and facilitate its removal by capitalizing on the “lotus-effect” where hydrophobic, oleophobic and super-amphiphobic properties are conferred to the surface by polymeric coatings containing appropriate nanocomposites. An exemplary coating contains fluorine and silicon nanocomposites with good roll off properties and very high water and oil contact angles. When used on rough surfaces like sandblasted glass, nanocoatings may act as a filler to provide stain resistance. A drawback of these “passive” technologies is that they are not optimal for use in high gloss surfaces because the lotus-effect is based on surface roughness.
Photocatalytic coatings are promising for promoting self-cleaning of organic stains. Upon the irradiation of sun light, a photocatalyst such as TiO2 chemically breaks down organic dirt that is then washed away by the water sheet formed on the super hydrophilic surface. As an example, the photocatalyst TiO2 was used to promote active fingerprint decomposition of fingerprint stains in U.S. Pat. Appl. Publ. 2009/104086. A major drawback to this technology is its limitation to use on inorganic surfaces due to the oxidative impairment of the polymer coating by TiO2. Also, this technology is less than optimal for automotive coatings due to a compatibility issue: TiO2 not only decomposes dirt, but also oxidizes polymer resins in paint.
Therefore, there is a need for new materials or coatings that can actively promote the removal of organic stains on surfaces or in coatings and minimize the requirement for maintenance cleaning.
The following summary is provided to facilitate an understanding of some of the innovative features unique to the present invention and is not intended to be a full description. A full appreciation of the various aspects of the invention can be gained by taking the entire specification, claims, drawings, and abstract as a whole.
Provided are compositions for facilitating removal of an organic stain from a surface, the composition including: a substrate or a coating formed of an organic crosslinkable polymer resin; and a lipase capable of enzymatically degrading a component of an organis staing, said lipase associated with, optionally entrapped within and crosslinked to, said substrate or coating, wherein said lipase is uniformly dispersed in said substrate or coating in protein aggregates having an average diameter of 10 micrometers or less.
Also provided are compositions that may be used as substrates or coatings to facilitate removal of a fingerprint from a surface of the substrate or coating, the composition including Provided are substrates or coatings that include an organic crosslinkable polymer resin; and a lipase capable of enzymatically degrading a fat or oil component of an organic stain, the lipase associated with said substrate or coating, and optionally lipase is uniformly dispersed in said substrate or coating in protein aggregates optionally having an average diameter of 10 micrometers or less.
The following description of aspect(s) of the invention is merely exemplary in nature and is in no way intended to limit the scope of the invention, its application, or uses, which may, of course, vary. The invention is described with relation to the non-limiting definitions and terminology included herein. These definitions and terminology are not designed to function as a limitation on the scope or practice of the invention but are presented for illustrative and descriptive purposes only.
A composition useful as a coating is provided where one or more proteins associated with the coating material are optionally chemically modified so as to improve coating activity lifetime during and following exposure of a coating to water. The coatings provided herein are bioactive coatings, with coatings including enzymes, optionally chemically modified enzymes, having several advantages over other coating materials in that they present improved lifetime after weathering and easy renewal of bioactivity by mild abrasion of the coating. Use of coatings containing chemically modified enzymes of the present invention allows one to regularly renew the bioactive surface as well as improve other qualities such as shine, protection from the elements, and water runoff.
The coatings according to some aspects demonstrate resistance to loss of activity due to weathering. Weathering as defined herein includes exposure to water, heat, UV light, or other insult either in the environment or in a laboratory. Coatings with chemically modified enzymes according to aspects of the present invention have unexpected resistance to weathering by exposure to water, such as water immersion. As such, the term “weathering” includes immersion in water.
It is appreciated that while the description herein is directed to coatings, the materials described herein may also be substrates or articles that do not require a coating thereon for promotion of organic stain removal. As such, the word “coating” as used herein means a material that is operable for layering on a surface of one or more substrates, or may comprise the substrate material itself. In some aspects, a “coating” is exclusive of a substrate such that it is a material that may be used to overlay a substrate. As such, the methods and compositions disclosed herein are generally referred to as an enzyme associated with a coating for exemplary purposes only. One of ordinary skill in the art appreciates that the description is equally applicable to substrates themselves.
The present disclosure is based on the catalytic activity of an enzyme to selectively degrade components of organic stains, thus, promoting active stain removal. Organic stains illustratively include organic polymers, fats, oils, or proteins. Compositions and processes as provided herein are provided for the active breakdown of organic stains by a coating, including water-stabilized active coating. The inventors unexpectedly discovered that certain enzyme containing coatings are rapidly inactivated upon exposure to water such that the expected life of the coating is reduced to the point of uselessness in the field. Among the nearly infinite possible mechanisms of promoting stability of coating bioactivity, the inventors discovered that the addition of one or more polymeric moieties on or with an enzyme prior to incorporation with a base provides for dramatically improved water-stability of the resulting coating material.
Compositions as provided herein have utility as a coating for the self-cleaning of organic stains such as food stains, insect stains, fingerprints, and other environmental or artificial insults.
In aspects, a water-stabilized bioactive coating material composition is provided including a base with an associated chemically modified enzyme or with an enzyme intermixed with a polymeric moiety, and optionally a first polyoxyethylene also associated with the base, where the first polyoxyethylene is independent of the enzyme (i.e., not covalently linked to the enzyme).
In aspects, a composition is a water-stabilized coating. The term “water-stabilized” denotes activity of the coating toward the self-cleaning or loosening of an associated organic stain, where the activity is increased by the presence of a chemically modified protein relative to the identical coating with a non-chemically modified protein. Water-stabilized optionally includes coatings that retain 50% to 90%, or any value or range therebetween, or more activity after coating immersion in water for 30 minutes. Water-stabilized optionally includes coatings that retain 15% or greater activity after coating immersion in water for 90 minutes.
In some aspects, a coating composition, including a water-stabilized coating, is a temporary coating. As used herein the term “temporary” is defined as operable for a time between 30 minutes and three months. It is appreciated that the outer limit of temporary is optionally defined by the environmental conditions a coating is subjected to. In some aspects, temporary is at or less than three months, optionally, less than 2 months, optionally less than 6, 5, 4, 3, 2, or 1 weeks, or any time or range of time therebetween. Optionally, temporary is at or less than 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1 day, or any time or range therebetween. In some embodiments, the term “temporary” is any time between application of an inventive composition to a substrate and immersion or contact with water for 30, 60, or 90 minutes, or more. The reduced enzyme activity after the temporary time period is optionally renewed by abrasion of the surface of the coating to expose previously buried enzyme to the surface.
A coating composition includes a base material. As used herein a base material includes one or more organic polymeric materials. The combination of one or more of these base materials with an associated chemically modified or unmodified enzyme, and optionally a first polyoxyethylene also associated with the base, where the first polyoxyethylene is independent of the enzyme (i.e., not covalently linked to the enzyme) form a bioactive material (synonymously protein-polymer composite material) that can be used as a substrate material or a coating, optionally a water stabilized substrate material or a coating. Illustrative examples of base materials useful for association with one or more enzymes, optionally chemically modified enzymes, are illustrated in U.S. Patent Application Publication Nos. 2008/0293117 and 2010/0279376.
Preparation of coating materials, and optionally water stabilized bioactive coating materials, are illustratively achieved by association, optionally by dissolving, aqueous solutions of enzyme and one or more non-aqueous organic solvent-borne polymers. Enzyme is optionally dispersed in solvent-borne resin prior to curing. Dispersing of enzyme contrasts with forming large average aggregates (e.g. greater than 5 μm in diameter) of the enzyme that diminish the functionality of the enzymes and enzyme containing bioactive materials. Enzymes are optionally dispersed in the polymeric materials such that enzymes are unassociated with other bioactive proteins and/or form relatively small particles by average diameter (e.g., less than 10 μm or less than 5 μm) of associated proteins. Illustratively, the average particle size of lipase particles in the protein-polymer composite material is less than 10 μm (average diameter) such as in the range of 1 nm to 10 μm, inclusive. Illustratively, the average particle size of enzyme particles in the protein-polymer composite material is less than 5 μm (average diameter) such as in the range of 1 nm to 5 μm. In some embodiments, the average particle size is 5000, 4000, 3000, 2000, 1000, 900, 800, 700, 600, 500, 400, 300, 200, 100, 50, 25, 20, 15, 10, 5, 1 nm, or less or any value or range at or less than 0.1 nm to 5000 nm. In some embodiments, the average particle size does not exceed 5, 4, 3, 2, or 1 μm. Optionally, the average particle size is 1 μm or less.
Curable protein-polymer compositions are optionally two-component solvent-borne (2K SB) compositions. Optionally, one component systems (1K) are similarly operable. Illustratively, an enzyme is entrapped in a coating material such as a latex or enamel paint, varnish, polyurethane gels, or other coating materials. Illustrative examples of incorporating enzymes into paints are presented in U.S. Pat. No. 5,998,200.
In two-component systems, the two components are optionally mixed shortly before use, for instance, application of the curable protein-polymer composition to a substrate to form an enzyme containing coating such as a bioactive clear coat. Generally described, the first component contains a crosslinkable polymer resin and the second component contains a crosslinker. Thus, the emulsion is a first component containing a crosslinkable resin and the crosslinker is a second component, mixed together to produce the curable protein-polymer composition.
A polymer resin included in methods and compositions of the present invention can be any film-forming polymer useful in coating or substrate compositions, illustratively clear coat compositions. Such polymers illustratively include, aminoplasts, melamine formaldehydes, carbamates, polyurethanes, polyacrylates, epoxies, polycarbonates, alkyds, vinyls, polyamides, polyolefins, phenolic resins, polyesters, polysiloxanes, and combinations of any of these or other polymers.
In some embodiments, a polymer resin is crosslinkable. Illustratively, a crosslinkable polymer has a functional group characteristic of a crosslinkable polymer. Examples of such functional groups illustratively include acetoacetate, acid, amine, carboxyl, epoxy, hydroxyl, isocyanate, silane, vinyl, other operable functional groups, and combinations thereof.
Examples of organic crosslinkable polymer resins include aminoplasts, melamine formaldehydes, carbamates, polyurethanes, polyacrylates, epoxies, polycarbonates, alkyds, vinyls, polyamides, polyolefins, phenolic resins, polyesters, polysiloxanes, or combinations thereof.
A cross linking agent (crosslinker) is optionally included in the composition. The particular crosslinker selected depends on the particular polymer resin used. Non-limiting examples of crosslinkers include compounds having functional groups such as isocyanate functional groups, epoxy functional groups, aldehyde functional groups, or acid functionality.
In particular embodiments of protein-polyurethane composite materials, a polymer resin is a hydroxyl-functionalized acrylic polymer and the crosslinker is a polyisocyanate.
A polyisocyanate, optionally a diisocyanate, is a crosslinker reacted with the hydroxyl-functionalized acrylic polymer according to embodiments of the present invention. Aliphatic polyisocyanates are optional polyisocyanates used in processes for making protein-polymer composite materials for clearcoat applications such as in automotive clearcoat applications. Non-limiting examples of aliphatic polyisocyanates illustratively include 1,4-butylene diisocyanate, 1,4-cyclohexane diisocyanate, 1,2-diisocyanatopropane, 1,3-diisocyanatopropane, ethylene diisocyanate, lysine diisocyanate, 1,4-methylene bis (cyclohexyl isocyanate), diphenylmethane 4,4′-diisocyanate, an isocyanurate of diphenylmethane 4,4′-diisocyanate, methylenebis-4,4′-isocyanatocyclohexane, 1,6-hexamethylene diisocyanate, an isocyanurate of 1,6-hexamethylene diisocyanate, isophorone diisocyanate, an isocyanurate of isophorone diisocyanate, p-phenylene diisocyanate, toluene diisocyanate, an isocyanurate of toluene diisocyanate, triphenylmethane 4,4′,4″-triisocyanate, tetramethyl xylene diisocyanate, and meta-xylene diisocyanate.
Curing modalities are those typically used for conventional curable polymer compositions. Illustratively, curing is achieved by application of heat, UV light, or combinations thereof. Optionally, a coating composition is cured by exposure to oxygen or other atmosphere. Some embodiments are cured spontaneously without necessary application of other curing affectors or conditions.
Coating materials, including water stabilized bioactive coating materials, are optionally thermoset protein-polymer composite materials. For example, a substrate or coating material is optionally cured by thermal curing. A thermal polymerization initiator is optionally included in a curable composition. Thermal polymerization initiators illustratively include free radical initiators such as organic peroxides and azo compounds. Examples of organic peroxide thermal initiators illustratively include benzoyl peroxide, dicumylperoxide, and lauryl peroxide. An exemplary azo compound thermal initiator is 2,2′-azobisisobutyronitrile.
Conventional curing temperatures and curing times can be used in processes according to embodiments of the present invention. For example, the curing time at specific temperatures, or under particular curing conditions, is determined by the criteria that the cross-linker functional groups are reduced to less than 5% of the total present before curing. Cross-linker functional groups can be quantitatively characterized by FT-IR or other suitable method. For example, the curing time at specific temperatures, or under particular curing conditions, for a polyurethane protein-polymer composite of the present invention can be determined by the criteria that the cross-linker functional group NCO is reduced to less than 5% of the total present before curing. The NCO group can be quantitatively characterized by FT-IR. Additional methods for assessing the extent of curing for particular resins are well-known in the art. Illustratively, curing may include evaporation of a solvent or by exposure to actinic radiation, such as ultraviolet, electron beam, microwave, visible, infrared, or gamma radiation.
One or more additives are optionally included for modifying the properties of the coating materials, including water stabilized bioactive coating materials and/or the admixture of organic solvent and polymer resin, the aqueous enzyme solution, the emulsion, and/or the curable composition. Illustrative examples of such additives include a UV absorbing agent, a plasticizer, a wetting agent, a preservative, a surfactant, a lubricant, a pigment, a filler, and an additive to increase sag resistance.
A substrate or coating including an enzyme is illustratively an admixture of a polymer resin, a surfactant and a non-aqueous organic solvent, mixed to produce an emulsion. The term “surfactant” refers to a surface active agent that reduces the surface tension of a liquid in which it is dissolved, or that reduces interfacial tension between two liquids or between a liquid and a solid.
Surfactants can be of any variety including amphoteric, silicone-based, fluorosurfactants, anionic, cationic and nonionic such as described in K. R. Lange, Surfactants: A Practical Handbook, Hanser Gardner Publications, 1999; and R. M. Hill, Silicone Surfactants, CRC Press, 1999, incorporated herein by reference. Examples of anionic surfactants illustratively include alkyl sulfonates, alkylaryl sulfonates, alkyl sulfates, alkyl and alkylaryl disulfonates, sulfonated fatty acids, sulfates of hydroxyalkanols, sulfosuccinic acid esters, sulfates and sulfonates of polyethoxylated alkanols and alkylphenols. Examples of cationic surfactants include quaternary surfactants and amineoxides. Examples of nonionic surfactants include alkoxylates, alkanolamides, fatty acid esters of sorbitol or manitol, and alkyl glucamides. Examples of silicone-based surfactants include siloxane polyoxyalkylene copolymers.
When a bioactive coating is contacted with biological material to produce a biological stain, the enzyme or combinations of enzymes contact the stain, or components thereof. The contacting allows the enzymatic activity of the enzyme to interact with and enzymatically alter the components of the stain improving its removal from the substrate or coating.
A composition includes at least one active protein that serves to produce the bioactive coating. An active protein is a macromolecule that has functional activity such as that of an enzyme illustratively a protease or hydrolase. A “protein” as defined herein as three or more natural, synthetic, or derivative amino acids covalently linked by a peptide bond and possessing the activity of an enzyme. Accordingly, the term “protein” as used herein includes between 3 and about 1000 or more amino acids or having a molecular weight in the range of about 150-350,000 Daltons. A protein is a molecule with a contiguous molecular sequence three amino acids or greater in length, optionally matching the length of a biologically produced proteinaceous molecule encoded by the genome of an organism. Examples of proteins include an enzyme, an antibody, a receptor, a transport protein, a structural protein, or a combination thereof. Proteins are capable of specifically interacting with another substance such as a ligand, drug, substrate, antigen, or hapten. It is appreciated that a protein may be chemically modified by the addition of one or more homo or heteropolymeric moieties as described herein. The term “analogue” is exclusive of chemical modification with a homo or heteropolymeric group with the exception of biotinylation.
A protein is optionally modified from a naked polypeptide sequence such as by the addition or subtraction of one or more molecules of phosphorus, sulfur, or by the addition of a pendent group such as a biotin, avidin, fluorophore, lumiphore, or other pendent group suitable for purification, detection, or altering solubility or other characteristic of a protein.
The description herein is directed to a protein that is an enzyme, but it is appreciated that other protein active components are similarly operable herein. An enzyme is optionally a bioactive enzyme. A bioactive enzyme is capable of cleaving a chemical bond in a molecule that is found in a biological organism, the environment, or in food. A coating that is bioactive contains one or more bioactive enzymes. An enzyme is optionally a protease that is capable of cleaving a peptide bond illustratively including a bacterial protease, or analogue thereof. A protein that functions as an enzyme is optionally identical to the wild-type amino acid sequence encoded by a gene, a functional equivalent of such a sequence, or a combination thereof. A protein is referred to as “wild-type” if it has an amino acid sequence that matches the sequence of a protein is found in an organism in nature. It is appreciated that a protein is optionally a functional equivalent to a wild-type enzyme, which includes a sequence and/or a structural analogue of a wild-type protein's sequence and/or structure and functions as an enzyme. The functional equivalent enzyme may possess similar or the same enzymatic properties as a wild-type enzyme, such as catalyzing chemical reactions of the wild-type enzyme's EC classification, and/or may possess other enzymatic properties, such as catalyzing the chemical reactions of an enzyme related to the wild-type enzyme by sequence and/or structure. An enzyme encompasses its functional equivalents that catalyze the reaction catalyzed by the wild-type form of the enzyme (e.g., the reaction used for EC Classification). As an illustrative non-limiting example, the term “amylase” encompasses any functional equivalent of an amylase that retains amylase activity though the activity may be altered such as by increased reaction rates, decreased reaction rates, altered substrate preference, increased or decreased substrate binding affinity, etc. Examples of functional equivalents include mutations to a wild-type enzyme sequence, such as a sequence truncation, an amino acid substitution, an amino acid modification, and/or a fusion protein, etc., wherein the altered sequence functions as an enzyme.
An enzyme is immobilized into or on coatings and catalyzes the degradation of organic stain components into smaller molecules. Without being limited to one particular theory, the smaller product molecules are less strongly adherent to a surface or coating such that gravity or gentle rinsing such as with water, air, or other fluid promotes removal of the organic stain material from the coating. Thus, the invention has utility as a composition and method for the active removal of organic stains from surfaces.
Enzymes are generally described according to standardized nomenclature as Enzyme Commission (EC) numbers. Examples of enzymes operable herein include: EC1, oxidoreductases; EC2, transferases; EC3, hydrolases; EC4, lyases; EC5, isomerases; or EC6, ligases. Enzymes in any of these categories can be included in a composition according to embodiments of the present invention.
In some embodiments, an included enzyme is a hydrolase such as a glucosidase, a protease, or a lipase. Non-limiting examples of glucosidases include amylases, chitinase, and lysozyme. Non-limiting examples of proteases include trypsin, chymotrypsin, thermolysin, subtilisin, papain, elastase, and plasminogen. Non-limiting examples of lipases include pancreatic lipase, lipoprotein lipase, and lipase PS. A lipase can include peptides having between 2 and about 1000 amino acids or having a molecular weight in the range of about 150-350,000 Daltons. Illustrative examples of proteins that function as enzymes are included in U.S. Patent Application Publication No: 2010/0210745.
Amylase is an enzyme present in some embodiments of a coating composition. Amylases have activity that break down starch. Several types of amylases are operable herein illustratively including α-amylase (EC 3.2.1.1) responsible for endohydrolysis of (1->4)-alpha-D-glucosidic linkages in oligosaccharides and polysaccharides. α-Amylase is illustratively derived from Bacillus subtilis and has the sequence found at Genbank Accession No: ACM91731 (SEQ ID NO: 1), or an analogue thereof and encoded by the nucleotide sequence of SEQ ID NO: 2. A specific example is α-amylase from Bacillus subtilis available from Sigma-Aldrich Co., St. Louis, Mo. Additional α-amylases include those derived from Geobacillus stearothermophilus (Accession No: AAA22227), Aspergillus oryzae (Accession No: CAA31220), Homo sapiens (Accession No: BAA14130), Bacillus amyloliquefaciens (Accession No: ADE44086), Bacillus lichemformis (Accession No: CAA01355), or other organism, or analogues thereof. It is appreciated that β-amylases, γ-amylases, or analogues thereof from a variety of organisms are similarly operable in a protein-polymer composition.
Specific examples of amylase enzymes illustratively have 1000 U/g protease activity or more wherein one (1) U (unit) is defined as the amount of enzyme that will liberate the non-protein digestion product form potato starch of Zulkowsky (e.g. starch, treated with glycerol at 190° C.; Ber. Deutsch. Chem. Ges, 1880; 13:1395). Illustratively, the amylase has activity anywhere at or between 1,000 U/g to 500,000 U/g, or greater. It is appreciated that lower activities are operable.
A protease is optionally a bacterial metalloprotease such as a member of the M4 family of bacterial thermolysin-like proteases of which thermolysin is the prototype protease (EC 3.4.24.27) or analogues thereof. A protease is optionally the bacterial neutral thermolysin-like-protease (TLP) derived from Bacillus stearothermophilus (Bacillus thermoproteolyticus Var. Rokko) (illustratively sold under the trade name “THERMOASE C160” available from Amano Enzyme U.S.A., Co. (Elgin, Ill.)) or analogues thereof. A protease is optionally any protease presented in de Kreig, et al., J Biol Chem, 2000; 275(40):31115-20. Illustrative examples of a protease include the thermolysin-like-proteases from Bacillis cereus (Accession No. P05806), Lactobacillis sp. (Accession No. Q48857), Bacillis megaterium (Accession No. Q00891), Bacillis sp. (Accession No. Q59223), Alicyclobacillis acidocaldarious (Accession No. Q43880), Bacillis caldolyticus (Accession NO. P23384), Bacillis thermoproteolyticus (Accession No. P00800), Bacillus stearothermophilus (Accession No. P43133), Bacillus subtilis (Accession No. P06142), Bacillus amyloliquefaciens (Accession No. P06832), Lysteria monocytogenes (Accession No: P34025; P23224), among others known in the art.
A wild-type protease is a protease that has an amino acid sequence identical to that found in an organism in nature. An illustrative example of a wild-type protease is that found at GenBank Accession No. P06874 and SEQ ID NO: 3, with the nucleotide sequence encoding SEQ ID NO: 3 found in Takagi, M., et al., J. Bacteriol., 1985; 163(3):824-831 and SEQ ID NO: 4.
Methods of screening for protease activity are known and standard in the art. Illustratively, screening for protease activity in a protease protein or analogue thereof illustratively includes contacting a protease or analogue thereof with a natural or synthetic substrate of a protease and measuring the enzymatic cleavage of the substrate. Illustrative substrates for this purpose include casein of which is cleaved by a protease to liberate folin-positive amino acids and peptides (calculated as tyrosine) that are readily measured by techniques known in the art. The synthetic substrate furylacryloylated tripeptide 3-(2-furylacryloyl)-L-glycyl-L-leucine-L-alanine obtained from Bachem AG, Bubendorf, Switzerland is similarly operable.
Specific examples of proteases illustratively have 10,000 Units/g protease activity or more. In some embodiments, a protease is a thermolysin wherein one (1) U (unit) is defined as the amount the enzyme that will liberate the non-proteinaceous digestion product from milk casein (final concentration 0.5%) to give Folin's color equivalent to 1 μmol of tyrosine per minute at the reaction initial reaction stage when a reaction is performed at 37° C. and pH 7.2. Illustratively, the protease activity is anywhere between 10,000 PU/g to 1,500,000 U/g inclusive or greater. It is appreciated that lower protease activities are operable. Protease activity is optionally in excess of 300,000 U/g. Optionally, protease activity is between 300,000 U/g and 2,000,000 U/g or higher.
A protein is optionally a lipase. A wild-type lipase is a lipase that has an amino acid sequence identical to that found in an organism in nature. An illustrative example of a wild-type lipase is that found at GenBank Accession No. ACL68189 and SEQ ID NO: 5. An exemplary nucleotide sequence encoding a wild-type lipase is found at Accession No. FJ536288 and SEQ ID NO: 6.
Lipase activity is illustratively defined in Units/gram. 1 Unit illustratively corresponds to the amount of enzyme that hydrolyzes 1 μmol acetic acid per minute at pH 7.4 and 40° C. using the substrate triacetin (Sigma-Aldrich, St. Louis, Mo., Product No. 90240). The lipase of SEQ ID NO: 5 may have an activity of 200 Units/gram.
Methods of screening for lipase activity are known and standard in the art. Illustratively, screening for lipase activity in a lipase protein or analogue thereof illustratively includes contacting a lipase or analogue thereof with a natural or synthetic substrate of a lipase and measuring the enzymatic cleavage of the substrate. Illustrative substrates for this purpose include tributyrin and triacetin both of which are cleaved by a triacylglycerol lipase to liberate butyric acid or acetic acid, respectively, that is readily measured by techniques known in the art.
A protein optionally functions with one or more cofactor ions or proteins. A cofactor ion is illustratively a zinc, cobalt, or calcium.
Cloning, expressing, and purifying any protein operable herein is achievable by methods ordinarily practiced in the art illustratively by methods disclosed in: Molecular Cloning: A Laboratory Manual, 2nd ed., vol. 1-3, ed. Sambrook et al., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1989; Current Protocols in Molecular Biology, ed. Ausubel et al., Greene Publishing and Wiley-Interscience, New York, 1992 (with periodic updates); and Short Protocols in Molecular Biology, ed. Ausubel et al., 52 ed., Wiley-Interscience, New York, 2002.
Naturally derived amino acids present in a protein illustratively include the common amino acids alanine, cysteine, aspartic acid, glutamic acid, phenylalanine, glycine, histidine, isoleucine, lysine, leucine, methionine, asparagine, proline, glutamine, arginine, serine, threonine, valine, tryptophan, and tyrosine. It is appreciated that less common derivatives of amino acids that are either found in nature or chemically altered are optionally present in a protein as well such as alpha-asparagine, 2-aminobutanoic acid or 2-aminobutyric acid, 4-aminobutyric acid, 2-aminocapric acid (2-aminodecanoic acid), 6-aminocaproic acid, alpha-glutamine, 2-aminoheptanoic acid, 6-aminohexanoic acid, alpha-aminoisobutyric acid (2-aminoalanine), 3-aminoisobutyric acid, beta-alanine, allo-hydroxylysine, allo-isoleucine, 4-amino-7-methylheptanoic acid, 4-amino-5-phenylpentanoic acid, 2-aminopimelic acid, gamma-amino-beta-hydroxybenzenepentanoic acid, 2-aminosuberic acid, 2-carboxyazetidine, beta-alanine, beta-aspartic acid, biphenylalanine, 3,6-diaminohexanoic acid, butanoic acid, cyclobutyl alanine, cyclohexylalanine, cyclohexylglycine, N5-aminocarbonylornithine, cyclopentyl alanine, cyclopropyl alanine, 3-sulfoalanine, 2,4-diaminobutanoic acid, diaminopropionic acid, 2,4-diaminobutyric acid, diphenyl alanine, N,N-dimethylglycine, diaminopimelic acid, 2,3-diaminopropanoic acid, S-ethylthiocysteine, N-ethylasparagine, N-ethylglycine, 4-aza-phenylalanine, 4-fluoro-phenylalanine, gamma-glutamic acid, gamma-carboxyglutamic acid, hydroxyacetic acid, pyroglutamic acid, homoarginine, homocysteic acid, homocysteine, homohistidine, 2-hydroxyisovaleric acid, homophenylalanine, homoleucine, homoproline, homoserine, homoserine, 2-hydroxypentanoic acid, 5-hydroxylysine, 4-hydroxyproline, 2-carboxyoctahydroindole, 3-carboxylsoquinoline, isovaline, 2-hydroxypropanoic acid (lactic acid), mercaptoacetic acid, mercaptobutanoic acid, sarcosine, 4-methyl-3-hydroxyproline, mercaptopropanoic acid, norleucine, nipecotic acid, nortyrosine, norvaline, omega-amino acid, ornithine, penicillamine (3-mercaptovaline), 2-phenylglycine, 2-carboxypiperidine, sarcosine (N-methylglycine), 2-amino-3-(4-sulfophenyl)propionic acid, 1-amino-1-carboxycyclopentane, 3-thienylalanine, epsilon-N-trimethyllysine, 3-thiazolylalanine, thiazolidine 4-carboxylic acid, alpha-amino-2,4-dioxopyrimidinepropanoic acid; and 2-naphthylalanine.
A protein is obtained by any of various methods known in the art illustratively including isolation from a cell or organism, chemical synthesis, expression of a nucleic acid sequence, and partial hydrolysis of proteins. Chemical methods of protein synthesis are known in the art and include solid phase peptide synthesis and solution phase peptide synthesis or by the method of Hackeng, T M, et al., Proc Natl Acad Sci USA, 1997; 94(15):7845-50. A protein may be a naturally occurring or non-naturally occurring protein. The term “naturally occurring” refers to a protein endogenous to a cell, tissue or organism and includes allelic variations. A non-naturally occurring protein is synthetic or produced apart from its naturally associated organism or is modified and is not found in an unmodified cell, tissue or organism.
Modifications and changes can be made in the structure of a protein and still obtain a molecule having similar characteristics as an active enzyme (e.g., a conservative amino acid substitution). For example, certain amino acids can be substituted for other amino acids in a sequence without appreciable loss of activity or optionally to reduce or increase the activity of an unmodified protein. Because it is the interactive capacity and nature of a protein that defines the protein's functional activity, certain amino acid sequence substitutions can be made in a protein sequence and nevertheless obtain a protein with like or other desired properties. Proteins with an amino acid sequence that is not 100% identical to that found in nature are termed analogues. An analogue optionally includes one or more amino acid substitutions, modifications, deletions, additions, or other change recognized in the art with the proviso that any such change produces a protein with the same type of activity (e.g. hydrolase) as the wild-type sequence. In making such changes, the hydropathic index, or the hydrophilicity of amino acids can be considered. In such changes, the substitution using amino acids whose hydropathic indices or hydrophilicity values are within ±2, those within ±1, and those within ±0.5 are optionally used.
Amino acid substitutions are optionally based on the relative similarity of the amino acid side-chain substituents, for example, their hydrophobicity, hydrophilicity, charge, size, and the like. Exemplary substitutions that take various of the foregoing characteristics into consideration are well known to those of skill in the art and include (original residue: exemplary substitution): (Ala: Gly, Ser), (Arg: Lys), (Asn: Gln, His), (Asp: Glu, Cys, Ser), (Gln: Asn), (Glu: Asp), (Gly: Ala), (His: Asn, Gln), (Ile: Leu, Val), (Leu: Ile, Val), (Lys: Arg), (Met: Leu, Tyr), (Ser: Thr), (Thr: Ser), (Tip: Tyr), (Tyr: Trp, Phe), and (Val: Ile, Leu). In particular, embodiments of the proteins can include analogues having about 50%, 60%, 70%, 80%, 90%, 95%, or 99% sequence identity to a wild-type protein.
It is further appreciated that the above characteristics are optionally taken into account when producing a protein with reduced or increased enzymatic activity. Illustratively, substitutions in a substrate binding site, exosite, cofactor binding site, catalytic site, or other site in a protein may alter the activity of the enzyme toward a substrate. In considering such substitutions the sequences of other known naturally occurring or non-naturally occurring like enzymes may be taken into account. Illustratively, a corresponding mutation to that of Asp213 in thermolysin is operable such as that done by Mild, Y, et al., Journal of Molecular Catalysis B: Enzymatic, 1996; 1:191-199. Optionally, a substitution in thermolysin of L144 such as to serine alone or along with substitutions of G8C/N60C/S65P are operable to increase the catalytic efficiency by 5-10 fold over the wild-type enzyme. Yasukawa, K, and Inouye, K, Biochimica et Biophysica Acta (BBA)-Proteins &Proteomics, 2007; 1774:1281-1288. The mutations in the bacterial neutral protease from Bacillus stearothermophilus of N116D, Q119R, D150E, and Q225R as well as other mutations similarly increase catalytic activity. De Kreig, A, et al., J. Biol. Chem., 2002; 277:15432-15438. De Kreig also teach several substitutions including multiple substitutions that either increase or decrease the catalytic activity of the protein. Id. and De Kreig, Eur J Biochem, 2001; 268(18):4985-4991. Other substitutions at these or other sites optionally similarly affect enzymatic activity. It is within the level of skill in the art and routine practice to undertake site directed mutagenesis and screen for subsequent protein activity such as by the methods of De Kreig, Eur J Biochem, 2001; 268(18):4985-4991.
A protein is optionally an analogue of a wild-type protein. An analogue of a protein has an amino acid sequence that when placed in similar conditions to a wild-type protein possess some level of the activity of a wild-type enzyme toward the same substrate. An analogue optionally has 500%, 250%, 200%, 150%, 110%, 99%, 98%, 97%, 96%, 95%, 94%, 93%, 92%, 91%, 90%, 85%, 80%, 75%, 70%, 60%, 50%, 25%, 10%, 5%, or any value or range of values therebetween, the activity of a wild-type protein. Any modification to a wild-type protein may be used to generate an analogue. Illustratively, amino acid substitutions, additions, deletions, cross-linking, removal or addition of disulfide bonds, or other modification to the sequence or any member of the sequence may be used to generate an analogue. An analogue is optionally a fusion protein that includes the sequences of two or more wild-type proteins, fragments thereof, or sequence analogues thereof.
Methods of screening for protein activity are known and standard in the art. Illustratively, screening for activity of an enzyme illustratively includes contacting an enzyme with a natural or synthetic substrate of an enzyme and measuring the enzymatic cleavage of the substrate. Illustrative substrates for this purpose include casein, which is cleaved by a protease to liberate folin-positive amino acids and peptides (calculated as tyrosine) that are readily measured by techniques known in the art. The synthetic substrate furylacryloylated tripeptide 3-(2-furylacryloyl)-L-glycyl-L-leucine-L-alanine obtained from Bachem AG, Bubendorf, Switzerland is similarly operable. Illustrative substrates of α-amylase include long chain carbohydrates such as amylose or amylopectin that make up starch. Other methods of screening for α-amylase activity include the colorimetric assay of Fischer and Stein, Biochem. Prep., 1961, 8, 27-33. It is appreciated that one of ordinary skill in the art can readily envision methods of screening for enzyme activity with the enzyme present in or on a variety of materials.
A protein is illustratively recombinant. Methods of cloning, synthesizing or otherwise obtaining nucleic acid sequences encoding a protein are known and standard in the art. Similarly, methods of cell transfection and protein expression are similarly known in the art and are applicable herein. Exemplary cDNA encoding the protein sequence of SEQ ID NO: 1 is the nucleotide sequence SEQ ID NO: 2. Exemplary cDNA encoding the protein sequence of SEQ ID NO: 3 is the nucleotide sequence found at accession number M11446 and SEQ ID NO: 4. Exemplary cDNA encoding the protein sequence of SEQ ID NO: 5 is the nucleotide sequence SEQ ID NO: 6
A protein may be coexpressed with associated tags, modifications, other proteins such as in a fusion protein, or other modifications or combinations recognized in the art. Illustrative tags include 6×His, FLAG, biotin, ubiquitin, SUMO, or other tag known in the art. A tag is illustratively cleavable such as by linking to protein via a target sequence that is cleavable by an enzyme known in the art illustratively including Factor Xa, thrombin, SUMOstar protein as obtainable from Lifesensors, Inc., Malvern, Pa., or trypsin. It is further appreciated that chemical cleavage is similarly operable with an appropriate cleavable linker.
Protein expression is illustratively accomplished following transcription of a protein nucleic acid sequence, translation of RNA transcribed from the protein nucleic acid sequence or analogues thereof. An analog of a nucleic acid sequence is any sequence that when translated to protein will produce a wild-type protein or an analogue of a wild-type protein. Protein expression is optionally performed in a cell based system such as in E. coli, Hela cells, or Chinese hamster ovary cells. It is appreciated that cell-free expression systems are similarly operable.
It is recognized that numerous analogues of protein are operable and within the scope of the present invention including amino acid substitutions, alterations, modifications, or other amino acid changes that increase, decrease, or not do alter the function of the protein sequence. Several post-translational modifications are similarly envisioned as within the scope of the present invention illustratively including incorporation of a non-naturally occurring amino acid, phosphorylation, glycosylation, addition of pendent groups such as biotin, avidin, fluorophores, lumiphores, radioactive groups, antigens, or other molecules.
As described above, a protein is optionally chemically modified by the addition of one or more polymeric moieties. Polymeric moieties optionally have a molecular weight ranging from 200 to 100,000 Daltons. Polymeric moieties are optionally linear, branched, liable, or combinations thereof. The polymeric moieties are optionally homomeric or heteromeric. Illustrative examples of polymeric moieties include one or more molecules of carbohydrate or polyoxyethylene (otherwise known as polyethylene glycol or “PEG”).
Illustrative examples of polymeric moieties include but are not limited to: polyalkyl alcohols and glycols (including heteroalkyl with, for example, oxygen) such as polyoxyethylenes and polyoxyethylene derivatives; dextrans including functionalized dextrans; styrene polymers; polyethylene and derivatives; polyanions including, but not limited to, polymers of heparin, polygalacturonic acid, mucin, nucleic acids and their analogs including those with modified ribosephosphate backbones, polypeptides of glutamate, aspartate, or combinations thereof, as well as carboxylic acid, phosphoric acid, and sulfonic acid derivatives of synthetic polymers; and polycations, including but not limited to, synthetic polycations based on acrylamide and 2-acrylamido-2 methylpropanetrimethylamine, poly(N-ethyl-4-vinylpyridine) or similar quarternized polypyridine, diethylaminoethyl polymers and dextran conjugates, polymyxin B sulfate, lipopolyamines, poly(allylamines) such as the strong polycation poly(dimethyldiallylammonium chloride), polyethyleneimine, polybrene, spermine, spermidine and proteins such as protamine, the histone polypeptides, polylysine, polyarginine and polyornithine; and mixtures and derivatives thereof. Suitable additional polymers are outlined in Roberts, M. J. et al. (2002) “Chemistry for peptide and protein PEGylation” Adv. Drug Deliv. Rev. 54, 459-476; Kinstler, O. et al. (2002) “Mono-N-terminal poly(ethylene glycol)-protein conjugates” Adv. Drug Deliv. Rev. 54; U.S. Application Ser. No. 60/360,722; U.S. Pat. Nos. 5,795,569; 5,766,581; EP 01064951; U.S. Pat. No. 6,340,742; WO 00176640; WO 002017; EP0822199A2; WO 0249673A2; U.S. Pat. Nos. 4,002,531; 5,183,550; 5,985,263; 5,990,237; 6,461,802; 6,495,659; 6,448,369; 6,437,025; 5,900,461; 6,413,507; 5,446,090; 5,672,662; 6,214,966; 6,258,351; 5,932,462; 5,919,455; 6,113,906; 5,985,236; WO 9428024A1; U.S. Pat. Nos. 6,340,742; 6,420,339; and WO 0187925A2.
Polyoxyethylene includes the generic structure —(CH2CH2O)n—, where n is an integer optionally from 2 to 2000. Optionally, n is an integer ranging from 50 to 500, optionally from 100 to 250, optionally from 150 to 250. Polyoxyethylene is optionally provided in a range of sizes attached to proteins using one or more of a variety of chemistries known in the art. Polyoxyelthylenes are optionally covalently associated with primary amines (e.g. lysine side chains or the protein N-terminus), thiols (cysteine residues), or histidines. Lysine occurs frequently on the surface of proteins, so binding of polyoxyethylene at lysine side chains produces a mix of reaction products. Since the pKa of the N-terminus is significantly different than the pKa of a typical lysine side chain, it is possible to specifically target the N-terminus for modification. Similarly, as most proteins contain very few free cysteine residues, cysteines (naturally occurring or engineered) may be targeted for site-specific interactions with polyoxyethylene.
Polyoxyethylene is optionally end capped where one end is end-capped with a relatively inactive group such as an alkoxy group, while the other end is a hydroxyl group that may be further modified by linker moieties. When the term “PEG” is used to describe polyoxyethylene the term “PEG” may be followed by a number (not being a subscript) that indicates a PEG moiety with the approximate molecular weight equal the number. Hence, “PEG10000” is a PEG moiety having an approximate molecular weight of 10,000 Daltons. The inventors have found that some embodiments including linear PEG10000 are superior to other PEG molecules. In some bases, enzymes that are covalently associated with a branched PEG, optionally an 8-arm branched PEG, produces superior resistance to weathering by contact or immersion in water.
The term “PEGylation” as used herein denotes modification of a protein by attachment of one or more PEG moieties via a linker at one or more amino acids. The polyoxyethylene (PEG) moiety is illustratively attached by nucleophilic substitution (acylation) on N-terminal α-amino groups or on lysine residue(s) on the gamma-positions, e.g., with PEG-succinimidyl esters. Optionally, polyoxyethylene moieties are attached by reductive alkylation—also on amino groups present in the protein using PEG-aldehyde reagents and a reducing agent, such as sodium cyanoborohydride. Optionally, polyoxyethylene moieties are attached to the side chain of an unpaired cysteine residue in a Michael addition reaction using for example PEG maleimide reagents. Polyoxyethylene moieties bound to a linker are optionally available from JenKem Technology USA, Allen, Tex. It is appreciated that any PEG molecule taught in U.S. Application Publication No: 2009/0306337 is operable herein. U.S. Application Publication No: 2009/0306337 also teaches methods of attaching PEG groups to a protein. PEG is optionally linked to a protein via an intermediate ester, amide, urethane, or other linkage dependent on the choice of PEG substrate and position of modification on a protein.
In some embodiments, a protein is an analogue of a hydrolase with the inclusion of additional cysteines to provide site specific incorporation sites for polyoxyethylene. In some embodiments, lysine or histidine residues are substituted with alternative amino acids that do not possess a target primary amine so as to prevent binding of a molecule of polyoxyethylene at that site. The choice of amino acid residues such as cysteines, lysines, or histidines to remove depends on the desired extent of modification. Optionally, simulation computer programs are used to predict whether modification with a polymer will interfere with the function of the protein as described in U.S. Pat. No. 7,642,340.
Proteins used in the inventions herein are optionally mono-substituted, i.e., having only one polymeric moiety attached to a single amino acid residue in the protein molecule or to a N-terminal amino acid residue. Alternatively, two, three, four, or more polymeric moieties are present on a single protein. In embodiments where protein includes more than one polymeric moiety, it optionally has the same moiety attached to each associated amino acid group or to the N-terminal amino acid residue. However, the individual polymer groups may also vary from each other in size and length and differ between locations on the protein.
Reversible binding of one or more polymeric moieties at one or more sites on a protein is optionally used. In these embodiments, the polymer is covalently attached but is liable upon exposure to weathering such as for example heating, water washing, or simply over time. The liable bond is optionally the bond between the protein and the polymer or within a linker present between a protein and a polymer.
Processes and compositions disclosed herein include a protein, optionally one or more active chemically modified proteins, incorporated into a base to form a coating material. The protein is optionally non-covalently associated and/or covalently attached to the base material or is otherwise associated therewith such as by bonding to the surface or by intermixing with the base material during manufacture such as to produce entrapped protein. In some embodiments, the protein is covalently attached to the base material either by direct covalent interaction between the protein and one or more components of the base material or by association via a linker.
There are several ways to associate protein with a base in a coating. One of which involves the application of covalent bonds. Specifically, free amine groups of the protein are optionally covalently bound to an active group of the base. Such active groups include alcohol, thiol, aldehyde, carboxylic acid, anhydride, epoxy, ester, or any combination thereof. This method of incorporating protein delivers unique advantages. First, the covalent bonds tether the proteins permanently to the base and thus place them as an integral part of the final composition with much less, if any at all, leakage of the protein. Second, the covalent bonds provide extended enzyme lifetime. Over time, proteins typically lose activity because of the unfolding of their polypeptide chains. Chemical bonding such as covalent bonding effectively restricts such unfolding, and thus improves the protein life. The life of a protein is typically determined by comparing the amount of activity reduction of a protein that is free or being physically adsorbed with that of a protein covalently-immobilized over a period of time.
A protein is optionally associated with a base at a ratio of 1:1 to 1:20 (enzyme:base) by weight. Optionally, a protein is associated with a base at a ratio of 1:2 to 1:15, optionally 1:4 to 1:12 by weight.
Proteins are optionally uniformly dispersed throughout the substrate network to create a homogenous protein platform.
Chemical methods of protein attachment to materials will naturally vary depending on the functional groups present in the protein and in the material components. Many such methods exist. For example, methods of attaching proteins (such as enzymes) to other substances are described in O'Sullivan et al, Methods in Enzymology, 1981; 73:147-166 and Erlanger, Methods in Enzymology, 1980; 70:85-104.
Proteins are optionally present in a coating that is layered upon a substrate wherein the protein is optionally entrapped in the base material, admixed therewith, modified and integrated into the base material or layered upon a base material.
A coating composition, including a water-stabilized coating composition, optionally includes one or more additives, optionally for modifying the properties of the composition material. Illustrative examples of such additives include one or more light stabilizers such as a UV absorber or radical scavenger illustratively including those described in U.S. patent application Ser. No. 13/024,794 or U.S. Pat. No. 5,559,163, a plasticizer, a wetting agent, a preservative, a surfactant, a lubricant, a pigment, a filler, and an additive to increase sag resistance.
A process optionally includes overlayering (coating) a substrate with a coating material, optionally a water-stabilized active coating material, such that the protein is capable of enzymatically degrading a component of an organic stain in contact with the active coating material. A substrate is any surface capable of being coated with an inventive coating. A substrate is optionally flexible or rigid with flexibility relative to that of a polyvinylchloride sheet with a thickness of 10 mm. A substrate has a first surface and a second surface wherein the first surface and the second surface are opposed. A coating is optionally overlayered on a substrate on a first surface, a second surface, both, or fully encapsulates a substrate. The coating of a substrate with a coating material, optionally a water-stabilized active coating material, provides a self-cleaning surface that promotes the removal or loosening of an organic stain when present on the coating.
The identity of a substrate is limited only by its ability to be coated with an inventive composition. Illustratively, a substrate is metal, wood, natural or synthetic polymers such as fiberglass or other plastics, resins, paints, lacquers, stone, leather, other material, or combinations thereof. A substrate is optionally an automotive body panel or portion thereof. A substrate is optionally a boat hull or portion thereof. A substrate is optionally a wood floor or a coated wood floor. A substrate optionally includes a subcoating such as wood coated with a polyurethane protectant, or a subcoating is a paint, varnish, or other protectant commonly found on substrate. A coating material, optionally a water-stabilized active coating material, optionally contacts the substrate by overlaying the subcoating material.
A coating material, including water-stabilized coatings according to embodiments of the present invention, provide good adhesion to substrates, protection against environmental insults, protection against corrosion, and further provide active properties of the protein. Thus, in certain embodiments, coatings, including of water-stabilized active coating material, provide enzyme activity on a substrate useful in numerous applications such as detection of an analyte which is a substrate for the enzyme or a ligand for a receptor, antibody or lectin. In some embodiments, coatings provide resistance against staining by enzyme digestion of one or more components of stain producing material.
When a coating material, and optionally a water-stabilized composition, is contacted with biological, food, or environmental material to produce an organic stain, the enzyme or combinations of enzymes contact the stain, or components thereof. The contacting allows the enzymatic activity of the protein to interact with and enzymatically alter components of the stain improving its removal from the substrate or coating.
Proteins are included in compositions according to embodiments of the present invention in amounts ranging from 0.1-50, 1-30, 1-20, 1-10, 2-8, 3-6, or other weight percent of the total weight of the material composition.
Enzyme containing coatings have a surface activity generally expressed in Units/cm2. Coatings including a thermolysin such as THERMOASE C160 (thermolysin from Bacillus stearothermophilus) optionally have functional surface activities prior to exposure to water of greater than 0.0075 Units/cm2. In some embodiments, thermolysin surface activity is between 0.0075 Units/cm2 and 0.05 Units/cm2 or any value or range therebetween. Optionally, thermolysin surface activity is between 0.0075 Units/cm2 and 0.1 Units/cm2 or any value or range therebetween. Optionally, thermolysin surface activity is between 0.01 Units/cm2 and 0.05 Units/cm2 or any value or range therebetween. In coatings containing α-amylase from Bacillis subtilis, typical surface activities prior to exposure to water are at or in excess of 0.01 Units/cm2. In some embodiments, α-amylase surface activity is between 0.01 Units/cm2 and 1.5 Units/cm2 or any value or range therebetween. Optionally, α-amylase surface activity is between 0.01 Units/cm2 and 2.5 Units/cm2 or any value or range therebetween. Optionally, α-amylase surface activity is between 0.01 Units/cm2 and 1.0 Units/cm2 or any value or range therebetween. In some embodiments, α-amylase surface activity is at or between 0.01 Units/cm2 and 4.0 Units/cm2. It is appreciated that higher surface activities are achievable by increasing the enzyme concentration, using enzyme with a higher specific activity such as an analogue of a wild-type enzyme, or by otherwise stabilizing enzyme activity during association with a base material.
It is appreciated that the inventive processes of facilitating stain removal will function at any temperature whereby the protein is active. Optionally, the inventive process is performed at 4° C. Optionally, an inventive process is performed at 25° C. Optionally, an inventive process is performed at ambient temperature. It is appreciated that the inventive process is optionally performed from 4° C. to 125° C., or any single temperature or range therebetween.
The presence of protein combined with the material of a substrate or a coating on a substrate, optionally, with water or other fluidic rinsing agent, breaks down stains for facilitated removal.
An inventive process includes providing a coating with an enzyme such that the enzyme is enzymatically active and capable to cleave or otherwise modify one or more components of an organic stain. In particular embodiments, an organic stain is based on organic matter such as that derived from an insect optionally an insect body, a fingerprint, foodstuffs, or from the environment.
An organic stain as defined herein is a stain, mark, or residue left behind after an organism, food, or environmental agent contacts a coating. An organic stain is not limited to marks or residue left behind after a coating is contacted by an insect body. Other sources of organic stains are illustratively: insect wings, legs, or other appendages; bird droppings; food or components of food; fingerprints or residue left behind after a coating is contacted by an organism; or other sources of organic stains such as bacteria or molecules present in water (or aqueous solvent) or soil.
Methods of preparing coating materials, optionally water-stabilized active coating materials, illustratively include association of aqueous solutions of protein and commercially available base materials by mixing such as by propeller mixing or hand mixing to a uniform or a non-uniform distribution of chemically modified protein to produce coating materials and optionally water-stabilized coating materials.
Various aspects of the present invention are illustrated by the following non-limiting examples. The examples are for illustrative purposes and are not a limitation on any practice of the present invention. It will be understood that variations and modifications can be made without departing from the spirit and scope of the invention.
Materials: α-Amylase KLEISTASE SD80 from Bacillus subtilis (EC 3.2.1.1), lipase (lipase A12 (E.C.3.1.1.3) from Aspergillus niger), Protease N, Protease A, Protin SD AY-10, B. sterothermophilus TLP (THERMOASE C160), THERMOASE GL30 (low activity preparation of B. sterothermophilus TLP), Lipase A12, and Lipase PS are obtained from AMANO Enzyme Inc. (Nagoya, JAPAN). Bovine serum albumin (BSA) from bovine serum, starch from potatoes, starch from wheat, maltose, sodium potassium tartrate, 3,5-dinitrosalicylic acid, Na2(PO4), NaCl, K2(PO4), casein, trichloroacetic acid, Folin & Ciocalteu's phenol reagent, Na2(CO3), sodium acetate, calcium acetate, tyrosine, p-nitrophenyl palmitate, ethanol, iodine, glucose, maltose, maltotriose, maltohexose, dextrin (10 kDa and 40 kDa) are obtained from Sigma Chemical Co., St. Louis, Mo., U.S.A. Aluminum panels and 8-path wet film applicator are purchased from Paul N. Gardner Company, Inc. (Pompano Beach, Fla.). An Oster blender (600 watts) and light mayonnaise are obtained from a local supermarket. Freeze-dried crickets are obtained from Fluker Laboratories (Port Allen, La.) and from PetSmart. Cricket bodies reportedly contain 58.3% protein. (D. Wang, et al., Entomologic Sinica, 2004; 11:275-283, incorporated herein by reference.). Polyethylene glycol (PEG) derivatives with succinimidyl ester of different molecular weights are obtained from Fishersci (Pittsburgh, Pa.).
Polyacrylate resin Desmophen A870. BA, and the crosslinker hexamethylene diisocyanate (HDI) based polyfunctional aliphatic polyisocyanate resin Desmodur N 3600 are obtained from Bayer Corp. (Pittsburgh, Pa.). The surfactant BYK-333 is obtained from BYK-Chemie (Wallingford, Conn.). 1-butanol and 1-butyl acetate are obtained from Sigma-Aldrich Co. (Missouri, USA). Aluminum paint testing panels are purchased from Q-Lab Co. (Cleveland, USA). All other reagents involved in the experiments are of analytical grade.
Lipase, α-amylase, and thermolysin are each prepared by ultrafiltration from raw powder. For α-amylase, a 150 mL solution from raw powder (6.75 g) is prepared in DI water. For thermolysin, a 150 mL solution of 1.5 g B. sterothermophilus thermolysin-like-protease (TLP) is prepared in DI water. For lipase, a 150 mL solution of 1.5 g lipase A12 is prepared in DI water. The insoluble large impurity in raw powder is removed by filtration over a 200 nm PTFE filter. The obtained solution has a protein concentration of 20 mg/mL (measured by the Bradford method) and is maintained on ice.
Ultrafiltration is performed using a 150 mL Amicon cell (cooled with ice) with a pressure of 55 psi and an ultrafiltration membrane with a cut-off of 30 kDa from Millipore (Billerica, Mass.). Ultrafiltration is repeated 3 times by refilling the cell back to 150 mL of 50 mM Phosphate Buffered Saline (PBS), pH=7.5 after each run. The final remaining purified protein solution is quantified by the Bradford method and diluted to the final working concentration used for chemical modification and production of coating materials in 50 mM PBS, pH=7.5. Coatings are made using a solution of 50, 100, 200, or 300 mg/mL of purified enzyme prior to or following chemical modification with one or more polymeric moieties.
PEGylation of enzyme. Purified enzyme (1 mL, 140 mg/ml) (α-amylase, thermolysin, or lipase) is mixed with PEG (monofunctional linear PEG10000, PEG12000, PEG20000, or 8-arm branched PEG (PEG N-Hydroxysuccinimide ester purchased from NANOCS Inc. (New York, N.Y.), in DMSO) derivatized with succinimidyl ester at a mole ratio of 1:5 enzyme:PEG. The 8-arm branched PEG has a molecular weight of 10,000 Daltons with a comb-shape structure. Each branch has a molecular weight of 18 1,200 Daltons. The structure of the 8-arm branched PEG has the following structure:
The reaction mixture is incubated in an ice bath for 4 hours under magnetic stirring at 800 rpm. Byproducts are removed by ultrafiltration (50K cutoff MW). Enzyme concentration is adjusted to 140 mg/ml for preparation of coating materials, to 1 mg/ml for SDS-PAGE, and to 0.1 mg/ml for activity assays. Some preparations further involve isolation of non-reacted PEG by filtration with a filter with an appropriate molecular weight cut-off for each PEG used in the PEGylation reactions.
Either unmodified (optionally fluorescently labeled) or PEG modified (optionally fluorescently labeled) α-amylase, thermolysin, lipase or combinations of enzymes are prepared in solution (600 μL, 140 mg/ml) as in Example 2 and 3 and admixed to 2.1 g Desmodur A870 together with 500 μL n-butyl acetate and 100 μL surfactant (17% v/v in butyl acetate) under vigorous stirring for 1 min by IKA RW 11 Lab-egg stirrer. The resulting whitish emulsion is subsequently added to 0.8 g Desmophen N3600 and again vigorously mixed for 1 min.
Test panels are coated with a coating composition by drawn-down application of wet film using an 8-path wet film applicator from Paul N. Gardner (Pompano Beach, Fla.) in the predetermined thickness of 20 μm onto aluminum panels or aluminum foil. The resultant coating is flashed 10 minutes in air and then cured in oven at 70° C. for 4 hours. An illustrative process of preparing a water-stabilized bioactive coating composition and applying the composition to a substrate is illustrated in
Coatings on the substrates are analyses by both fluorescent microscopy and scanning electron microscopy (SEM) to determine the enzyme dispersion in the base materials. For SEM characterization, cross-sectionized samples are prepared by coating on the heavy duty Reynolds Wrap® aluminium foil (Richmond, Va.) using an applicator. The fully cured coatings are torn and the resulting cross-sections of the fractured polymers are sputtered with Au—Pd. The unchemically modified (e.g. not PEGylated) enzymes show large average particle formation in excess of 5 μm.
In other embodiments, enzyme is intermixed with polyoxyethylene at similar concentrations to the covalently associated molecules, but without covalent attachment of the enzyme to the polymeric moiety. The enzyme/polymeric moiety solution is intermixed with base and cured as above.
Coated aluminum panels formed as in Example 4 are cut to test size of 1.2 cm×1.9 cm and subjected to weathering by submersion in room temperature DI water for 30 minutes with agitation. The test panels are removed and rinsed with flowing DI water for 20 seconds followed by assay for remaining enzyme activity. The immersion is repeated between 2 and 10 times and the remaining enzyme activity assayed.
Test panels coated with α-amylase containing coatings are assayed by determination of amydolytic activity by reacting test panels with the α-amylase substrate 1% w/v potato starch in 20 mM sodium phosphate buffer with 6.7 mM sodium chloride (pH 6.9). The substrate solution (2 mL) is added to one rectangular piece of the coated test panel (1.2 cm×1.9 cm) and incubated for 3 min at 25° C. The equivalent amount of reducing sugar produced is determined using a UV-VIS spectrometer (Cary 300-Varian Inc., Walnut Creek, Calif., USA) at 540 nm. One unit of α-amylase activity is defined as 1.0 mg of reducing sugar (calculated from a standard curve previously calibrated against maltose) released from starch in 3 min at room temperature.
Coatings prepared with thermolysin are assayed for proteolytic surface activity essentially following the method of Folin and Ciocalteau, J. Biol. Chem., 1927; 73: 627-50. Briefly, 1 mL of 2% (w/v) casein in sodium phosphate (0.05 M; pH 7.5) buffer solution is used as substrate together with 200 μl of sodium acetate, 5 mM calcium acetate (10 mM; pH 7.5). The substrate solution is pre-incubated in a water bath for 3 min to reach −37° C. The reaction is started by adding one piece of sample plate coated with B. sterothermophilus TLP based coating (1.2×1.9 cm) followed by shaking for 10 min at 200 rpm at which time the reaction is stopped by adding 1 ml of 110 mM trichloroacetic acid (TCA) solution. The mixture is incubated for 30 min at 37° C. prior to centrifugation. The equivalent of tyrosine in 400 μL of the TCA-soluble fraction is determined at 660 nm using 200 μL of 25% (v/v) Folin-Ciocalteau reagent and 1 mL 0.5 M sodium carbonate. One unit of activity is defined as the amount of enzyme hydrolyzing casein to produce absorbance equivalent to 1.0 μmol of tyrosine per minute at 37° C. This result is converted to Units/cm2.
An exemplary residual activity depicting the water-stability of coating preparations bases on α-amylase is depicted in
Preparation of organic stains and application to coated substrate and self-cleaning activity of coating preparations. For preparation of insect matter, 60 g of Freeze-dried crickets are chopped into powder by a blender (Oster, 600 watt) for 10 min. The stain solution is prepared by vigorously mixing 2 grams of cricket powder with 6 mL of DI water. A template of uniform spacing is used to apply the stain on the coating surface. The cricket stains are dried at 40° C. for 5 min. Each test panel is placed into a glass dish subjected to rinsing with 200 mL of DI water under 300 rpm shaking at RT for various times. The time of the stain removal is recorded. In order to reduce random error, the time of the first and last drop removed are not included. The average rinsing time of eight stain spots is averaged for stain removal time. Test panels coated with PEGylated thermolysin containing coatings provide improved stain removal by gentle rinsing as compared to panels coated with base material alone.
Amylase containing coatings of are placed on the plastic surfaces of standard compact disks or aluminum test panels as in Example 4. A 0.3 g sample of light mayonnaise is placed on various sections of the test panels followed by air dry at ambient conditions for 2 minutes prior to standing upright. Light mayonnaise includes large macromolecules such as fat and starch that contribute to its high viscosity and thus to the high frictional force on the coating surface that prevents gravity driven sliding of the mayonnaise when the test panel is tilted vertically. Coatings containing modified α-amylase catalyze the hydrolysis of the emulsifier resulting in tremendously lowered viscosity as a consequence of a phase separation at the stain-coating interface, thus allowing the stain to slide down the test panel when tilted vertically.
Similarly, aluminum test panels are coated with PEGylated α-amylase, PEG with no enzyme, or a coating with no enzyme or PEG as a control. Some test panels are immersed in water between 1 and 5 times as in Example 5 prior to contacting with a stain material. A drop of light mayonnaise is then placed on the panel, the panel is placed in a vertical position and any gravity driven movement of the light mayonnaise spot are monitored. The test panels coated with enzyme free coating or PEG only coatings show no movement of the light mayonnaise following tilting to a vertical position indicating the absence of coating bioactivity. The coating with PEGylated enzyme, however, shows significant self-cleaning as illustrated by lower adherence of the mayonnaise resulting in the spot moving down the test panel. The self-cleaning aspects of the coatings are also maintained after each of the water immersions.
The coatings of Example 4 containing PEGylated lipase are used to test removal of fingerprints from glass or transparent plastic surfaces. The self-cleaning of fingerprints by PEGylated lipase containing preparations is tested on glass substrates. Test panels are coated with either PEGylated lipase containing base materials or control materials (no enzyme) and incubated at room temperature 24 hours. In some experiments the coated surfaces are immersed in water between 1 and 5 times as in Example 5. The test panels are stained with human fingerprints or facial skin contact. The coated test panels are then incubated in an oven at 120° C. for 1 to 6 hours. For better visualization of any remaining finger prints, coatings are washed under running DI water (50 mL/sec) for 1 minute and dried using air. Prior to heating each coating is subjected to the same level of staining by fingerprints. Following baking, coatings without enzyme show significant residual staining while coatings containing PEGylated lipase show greatly reduced stain remaining with the level of residual fingerprint staining reduced with increased enzyme concentration. The level of stain removal is also maintained for test panels that were immersed in water.
Various modifications of the present invention, in addition to those shown and described herein, will be apparent to those skilled in the art of the above description. Such modifications are also intended to fall within the scope of the appended claims.
It is appreciated that all reagents are obtainable by sources known in the art unless otherwise specified or synthesized by one of ordinary skill in the art without undue experimentation. Methods of protein production and purification are similarly within the level of skill in the art.
Patents and publications mentioned in the specification are indicative of the levels of those skilled in the art to which the invention pertains. These patents and publications are incorporated herein by reference to the same extent as if each individual patent or publication was specifically and individually incorporated herein by reference.
The foregoing description is illustrative of particular embodiments of the invention, but is not meant to be a limitation upon the practice thereof. The following claims, including all equivalents thereof, are intended to define the scope of the invention.
This application is a divisional of U.S. patent application Ser. No. 16/900,386, filed on Jun. 12, 2020, which is a continuation of U.S. patent application Ser. No. 15/810,700 (now U.S. Pat. No. 11,015,149) filed Nov. 13, 2017, which is a continuation-in-part of U.S. patent application Ser. No. 14/812,087 filed on Jul. 29, 2015 (now U.S. Pat. No. 10,563,094), which is a continuation of U.S. patent application Ser. No. 13/229,277 filed Sep. 9, 2011 (now U.S. Pat. No. 9,121,016), as well as a continuation-in-part of U.S. patent application Ser. No. 15/193,242 filed on Jun. 27, 2016, which is a continuation of U.S. patent application Ser. No. 13/567,341 filed Aug. 6, 2012 (now U.S. Pat. No. 9,388,370), which in turn is a continuation-in-part of U.S. patent application Ser. No. 12/820,101, filed Jun. 21, 2010 (now U.S. Pat. No. 8,796,009), the entire contents of each of which are incorporated herein by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3220928 | Brenner | Nov 1965 | A |
| 3519538 | Messing et al. | Jul 1970 | A |
| 3672955 | Stanley | Jun 1972 | A |
| 3705938 | Hyman et al. | Dec 1972 | A |
| 3857934 | Bernstein et al. | Dec 1974 | A |
| 3935862 | Kraskin | Feb 1976 | A |
| 3957974 | Hata | May 1976 | A |
| 4016043 | Schuurs et al. | Apr 1977 | A |
| 4026814 | Johnson et al. | May 1977 | A |
| 4034078 | Van Horn | Jul 1977 | A |
| 4094744 | Hartdegen et al. | Jun 1978 | A |
| 4098645 | Hartdegen et al. | Jul 1978 | A |
| 4128686 | Kyle et al. | Dec 1978 | A |
| 4195127 | Hartdegen et al. | Mar 1980 | A |
| 4195128 | Thomas et al. | Mar 1980 | A |
| 4195129 | Fukui et al. | Mar 1980 | A |
| 4229536 | Defilippi | Oct 1980 | A |
| 4237591 | Ginocchio | Dec 1980 | A |
| 4297137 | Sachetto et al. | Oct 1981 | A |
| 4315828 | Church | Feb 1982 | A |
| 4322308 | Hooper et al. | Mar 1982 | A |
| 4385632 | Odelhoeg | May 1983 | A |
| 4539982 | Bailly | Sep 1985 | A |
| 4551187 | Church et al. | Nov 1985 | A |
| 4552813 | Grams | Nov 1985 | A |
| 4897352 | Chonde et al. | Jan 1990 | A |
| 4910234 | Yamamori et al. | Mar 1990 | A |
| 5112602 | Miki et al. | May 1992 | A |
| 5279955 | Pegg et al. | Jan 1994 | A |
| 5405766 | Kallury et al. | Apr 1995 | A |
| 5418146 | Joo et al. | May 1995 | A |
| 5420179 | Fourquier et al. | May 1995 | A |
| 5492821 | Callstrom et al. | Feb 1996 | A |
| 5496710 | Nagao et al. | Mar 1996 | A |
| 5508185 | Kawamura et al. | Apr 1996 | A |
| 5514671 | Lyon et al. | May 1996 | A |
| 5523027 | Otsuka | Jun 1996 | A |
| 5543309 | Pischel | Aug 1996 | A |
| 5559163 | Dawson et al. | Sep 1996 | A |
| 5593398 | Weimer | Jan 1997 | A |
| 5595728 | Brockett et al. | Jan 1997 | A |
| 5631343 | Binns et al. | May 1997 | A |
| 5643559 | Eigen et al. | Jul 1997 | A |
| 5719039 | Dordick et al. | Feb 1998 | A |
| 5728544 | Tanaka et al. | Mar 1998 | A |
| 5739004 | Woodson | Apr 1998 | A |
| 5739023 | Harada et al. | Apr 1998 | A |
| 5770188 | Hamade et al. | Jun 1998 | A |
| 5800804 | Laney | Sep 1998 | A |
| 5801140 | Langley et al. | Sep 1998 | A |
| 5817300 | Cook et al. | Oct 1998 | A |
| 5837483 | Hirata | Nov 1998 | A |
| 5868720 | Van Antwerp | Feb 1999 | A |
| 5876802 | Michael et al. | Mar 1999 | A |
| 5912408 | Trinh et al. | Jun 1999 | A |
| 5914367 | Dordick et al. | Jun 1999 | A |
| 5919689 | Powers et al. | Jul 1999 | A |
| 5942435 | Wheeler | Aug 1999 | A |
| H1818 | Potgieter et al. | Nov 1999 | H |
| 5981743 | Gross et al. | Nov 1999 | A |
| 5998200 | Bonaventura et al. | Dec 1999 | A |
| 5998512 | Schloman | Dec 1999 | A |
| 6030933 | Herbots et al. | Feb 2000 | A |
| 6060043 | Hayden et al. | May 2000 | A |
| 6080391 | Tsuchiya et al. | Jun 2000 | A |
| 6107392 | Antonelli et al. | Aug 2000 | A |
| 6150146 | Hamade et al. | Nov 2000 | A |
| 6265191 | Mizusawa et al. | Jul 2001 | B1 |
| 6291582 | Dordick et al. | Sep 2001 | B1 |
| 6303290 | Liu et al. | Oct 2001 | B1 |
| 6342386 | Powers et al. | Jan 2002 | B1 |
| 6472493 | Huynh-Ba | Oct 2002 | B1 |
| 6599627 | Yeo et al. | Jul 2003 | B2 |
| 6638526 | Deussen et al. | Oct 2003 | B1 |
| 6663949 | Tanaka et al. | Dec 2003 | B1 |
| 6713660 | Roe et al. | Mar 2004 | B1 |
| 6759220 | Lejeune et al. | Jul 2004 | B1 |
| 6818212 | Johansen | Nov 2004 | B2 |
| 6844028 | Mao et al. | Jan 2005 | B2 |
| 6855746 | Yoshitake et al. | Feb 2005 | B2 |
| 6875456 | Delest et al. | Apr 2005 | B2 |
| 6881711 | Gershun et al. | Apr 2005 | B1 |
| 6905733 | Russell et al. | Jun 2005 | B2 |
| 7164037 | Dietsche et al. | Jan 2007 | B2 |
| 7335400 | Russell et al. | Feb 2008 | B2 |
| 7632793 | Lang | Dec 2009 | B2 |
| 7687554 | Schellenberg et al. | Mar 2010 | B2 |
| 7932230 | Mcdaniel | Apr 2011 | B2 |
| 7939500 | Mcdaniel | May 2011 | B2 |
| 8008180 | Takahashi et al. | Aug 2011 | B2 |
| 8011381 | Newman et al. | Sep 2011 | B2 |
| 8011938 | Martin et al. | Sep 2011 | B2 |
| 8222015 | Wang et al. | Jul 2012 | B2 |
| 8252571 | Wang et al. | Aug 2012 | B2 |
| 8311297 | Du et al. | Nov 2012 | B2 |
| 8324295 | Jia et al. | Dec 2012 | B2 |
| 8388904 | Mcdaniel et al. | Mar 2013 | B1 |
| 8394618 | Buthe et al. | Mar 2013 | B2 |
| 8497248 | Mcdaniel | Jul 2013 | B2 |
| 8618066 | Mcdaniel | Dec 2013 | B1 |
| 8796009 | Jia et al. | Aug 2014 | B2 |
| 8932717 | Lee et al. | Jan 2015 | B2 |
| 9012196 | Buthe et al. | Apr 2015 | B2 |
| 9121016 | Jia et al. | Sep 2015 | B2 |
| 9193873 | Wang et al. | Nov 2015 | B2 |
| 9388370 | Wu et al. | Jul 2016 | B2 |
| 9428740 | Buthe et al. | Aug 2016 | B2 |
| 9828597 | Wang et al. | Nov 2017 | B2 |
| 10767141 | Wu | Sep 2020 | B2 |
| 10781438 | Wang | Sep 2020 | B2 |
| 10988714 | Buthe | Apr 2021 | B2 |
| 11015149 | Buthe | May 2021 | B2 |
| 11225654 | Wang | Jan 2022 | B2 |
| 11236323 | Wang | Feb 2022 | B2 |
| 11254898 | Buthe | Feb 2022 | B2 |
| 11834635 | Buthe | Dec 2023 | B2 |
| 20020019615 | Roe et al. | Feb 2002 | A1 |
| 20020192366 | Cramer et al. | Dec 2002 | A1 |
| 20030096383 | Shimizu et al. | May 2003 | A1 |
| 20030161789 | Ermantraut et al. | Aug 2003 | A1 |
| 20030166237 | Allermann et al. | Sep 2003 | A1 |
| 20040009159 | Polsenski et al. | Jan 2004 | A1 |
| 20040063831 | Sheppard et al. | Apr 2004 | A1 |
| 20040067279 | Delest et al. | Apr 2004 | A1 |
| 20040108608 | Ju et al. | Jun 2004 | A1 |
| 20040109853 | Mcdaniel | Jun 2004 | A1 |
| 20040175407 | Mcdaniel | Sep 2004 | A1 |
| 20040241497 | Sasaki et al. | Dec 2004 | A1 |
| 20040242831 | Tian et al. | Dec 2004 | A1 |
| 20040259746 | Warren et al. | Dec 2004 | A1 |
| 20050049166 | Huang | Mar 2005 | A1 |
| 20050058689 | Mcdaniel | Mar 2005 | A1 |
| 20050059128 | Arnold et al. | Mar 2005 | A1 |
| 20050079594 | Marion | Apr 2005 | A1 |
| 20050147579 | Schneider et al. | Jul 2005 | A1 |
| 20050176905 | Moon et al. | Aug 2005 | A1 |
| 20050255078 | Sakamoto et al. | Nov 2005 | A1 |
| 20050272141 | Crawford | Dec 2005 | A1 |
| 20060094626 | Horton | May 2006 | A1 |
| 20070093618 | Cheng et al. | Apr 2007 | A1 |
| 20070282070 | Adams et al. | Dec 2007 | A1 |
| 20080038241 | Schasfoort et al. | Feb 2008 | A1 |
| 20080108745 | Russell et al. | May 2008 | A1 |
| 20080119381 | Wang et al. | May 2008 | A1 |
| 20080145906 | Boucher et al. | Jun 2008 | A1 |
| 20080293117 | Wang et al. | Nov 2008 | A1 |
| 20080319193 | Grauert et al. | Dec 2008 | A1 |
| 20090023859 | Sakanoue et al. | Jan 2009 | A1 |
| 20090045056 | Berberich et al. | Feb 2009 | A1 |
| 20090104086 | Zax et al. | Apr 2009 | A1 |
| 20090238811 | Mcdaniel et al. | Sep 2009 | A1 |
| 20090274846 | Wada et al. | Nov 2009 | A1 |
| 20090325843 | Man et al. | Dec 2009 | A1 |
| 20100210745 | Mcdaniel et al. | Aug 2010 | A1 |
| 20100236582 | Heintz et al. | Sep 2010 | A1 |
| 20100248334 | Mcdaniel | Sep 2010 | A1 |
| 20100269731 | Tofte Jespersen et al. | Oct 2010 | A1 |
| 20100279376 | Wang et al. | Nov 2010 | A1 |
| 20100305014 | Miralles et al. | Dec 2010 | A1 |
| 20110076738 | Wang et al. | Mar 2011 | A1 |
| 20110195035 | Vondruska et al. | Aug 2011 | A1 |
| 20110240064 | Wales et al. | Oct 2011 | A1 |
| 20110250626 | Williams et al. | Oct 2011 | A1 |
| 20110311482 | Wang et al. | Dec 2011 | A1 |
| 20110312057 | Buthe et al. | Dec 2011 | A1 |
| 20120097194 | Mcdaniel et al. | Apr 2012 | A1 |
| 20120114961 | Lee et al. | May 2012 | A1 |
| 20120136119 | Davis et al. | May 2012 | A1 |
| 20120208923 | Jia et al. | Aug 2012 | A1 |
| 20120238005 | Benda et al. | Sep 2012 | A1 |
| 20120276617 | Jia et al. | Nov 2012 | A1 |
| 20130065291 | Jia et al. | Mar 2013 | A1 |
| 20130137159 | Buthe et al. | May 2013 | A1 |
| 20140083324 | Wales et al. | Mar 2014 | A1 |
| 20140141490 | Wang et al. | May 2014 | A1 |
| 20140193888 | Souter et al. | Jul 2014 | A1 |
| 20150175982 | Buthe et al. | Jun 2015 | A1 |
| 20150191607 | Mcdaniel | Jul 2015 | A1 |
| 20180044658 | Wang et al. | Feb 2018 | A1 |
| 20190153422 | Wang et al. | May 2019 | A1 |
| 20190153423 | Wang et al. | May 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 2003304222 | Jan 2005 | AU |
| 2004257205 | Jan 2005 | AU |
| 2010201732 | May 2010 | AU |
| 2538124 | Dec 2004 | CA |
| 616033 | Sep 1994 | EP |
| 670380 | Sep 1995 | EP |
| 609691 | May 1998 | EP |
| 896056 | Feb 1999 | EP |
| 1161502 | Dec 2004 | EP |
| 1551927 | Jul 2005 | EP |
| 1609826 | Dec 2005 | EP |
| 1644452 | Apr 2006 | EP |
| 1660596 | May 2006 | EP |
| 1661955 | May 2006 | EP |
| 2746378 | Jun 2014 | EP |
| 2832145 | May 2003 | FR |
| 1518746 | Jul 1978 | GB |
| 2410249 | Jul 2005 | GB |
| 2430436 | Mar 2007 | GB |
| 167413 | Dec 2010 | IL |
| 174122 | Sep 2011 | IL |
| 173658 | Apr 2012 | IL |
| 208769 | Apr 2012 | IL |
| 214668 | Jan 2013 | IL |
| 214669 | Jan 2013 | IL |
| 214670 | Jan 2013 | IL |
| 214671 | Jan 2013 | IL |
| 214672 | Jan 2013 | IL |
| 218129 | Sep 2013 | IL |
| 63077999 | Apr 1988 | JP |
| 63171678 | Jul 1988 | JP |
| 63202677 | Aug 1988 | JP |
| 01285188 | Nov 1989 | JP |
| 02068117 | Mar 1990 | JP |
| 02227471 | Sep 1990 | JP |
| 09038183 | Feb 1997 | JP |
| 9-059470 | Mar 1997 | JP |
| 2002526430 | Aug 2002 | JP |
| 2002332739 | Nov 2002 | JP |
| 2002537470 | Nov 2002 | JP |
| 2004506089 | Feb 2004 | JP |
| 2009511072 | Mar 2009 | JP |
| 2010510380 | Apr 2010 | JP |
| 6096748 | Mar 2017 | JP |
| 6192022 | Sep 2017 | JP |
| 8906278 | Jul 1989 | WO |
| 9516029 | Jun 1995 | WO |
| 9721804 | Jun 1997 | WO |
| 0050521 | Aug 2000 | WO |
| 0153010 | Jul 2001 | WO |
| 0216521 | Feb 2002 | WO |
| 2005026269 | Mar 2005 | WO |
| 2005103372 | Nov 2005 | WO |
| 2007017701 | Feb 2007 | WO |
| 2008000646 | Jan 2008 | WO |
| 2008063902 | May 2008 | WO |
| 2009155115 | Dec 2009 | WO |
| 2012110563 | Aug 2012 | WO |
| Entry |
|---|
| W. Stöber et al., “Controlled Growth of Monodisperse Silica Spheres in the micron Size Range”, Journal of Colloid and Interface Science 26, pp. 62-69 (1968). |
| K. Hans Brockerhoff et al., “Lipolytic Enzymes” , Academic Press, Inc., New York, New York, 1974, pp. 1-2, 4 and 8. |
| “Enzyme Nomenclature—Recommendations (1978) of the Nomenclature Committee of the international Union of Biochemistry”, Academic Press, New York, (1979) pp. 274-277. |
| Enzyme Nomenclature—Recommendations (1978) of the Nomenclature Committee of the international Union of Biochemistry, Academic Press, New York, (1979) pp. 234-239. |
| Kiyotaka Oyama et al., “[46] Production of Aspartame by Immobilized Thermoase”, Methods in Enzymology vol. 136, pp. 503-516 (1987). |
| Shigeru Yamanaka et al., “[37] Regiospecific Interesterification of Triglyceride with Celite-Adsorbed Lipase,” Methods in Enzymology, vol. 136, pp. 405-411 (1987). |
| N.F. Almeida et al., “Immobilization of Glucose Oxidase in Thin Polypyrrole Films: Influence of Polymerization Conditions and Film Thickness on the Activity and Stability of the Immobilized Enzyme” , Biotechnology and Bioengineering, vol. 42, pp. 1037-1045 (1993). |
| K. Bagi et al., “Immobilization and characterization of porcine pancreas lipase” , Eyzyme and Microbial Technology vol. 20, pp. 531-535 (1997). |
| Michelle V. Buchanan et al., “Chemical Characteristics of Fingerprints from Adults and Children,” in Forencsic Evidence Analysis & Crime Scene Investigation, 2941 Proc. SPIE 89 (Feb. 5, 1997). |
| G.W. Xing et al., “Influence of reaction conditions on syntheses of sweetener precursors catalyzed by thermolysin in tert—amyl alcohol” , J. Peptide Res. Vol. 52, Issue 4, pp. 300-304 (Date: 1998). |
| G.M. Mong et al. “Advanced Fingerprint Analysis Project Fingerprint Constituents,” Technical Report, Pacific Northwest Laboratory (1999). |
| M. Melchiors et al., “Recent developments in aqueous two-component polyurethane (2K-PUR) coatings” , Progress in Organic Coatings 40 (2000), pp. 99-109, p. 100, first complete paragraph. |
| Green, Philip, “Fineness of Grind”, European Coatings Journal, (2003), Issue 10, p. 53. |
| Yu et al. Biotechnol Lett. Apr. 2004; 26(8): 629-33 (Year: 2004). |
| The American Heritage Stedman's Medical Dictionary, Second Edition, (Copyright 2007 and 2004, Houghton Mifflin), pp. 463-464, 884. |
| A. Koohestanian et al., “The Separation Method for Removing of Colloidal Particles from Raw Water” , American-Eurasian J. Agric. & Environ. Sci., 4 (2): pp. 266-273 (2008). |
| Bo Chen et al., “Candida antarctica Lipase B Chemically Immobilized on Epoxy-Activated Micro- and Nanobeads: Catalysts for Polyester Synthesis”, Biomacromolecules (published Jan. 16, 2008), vol. 9, Issue 2, pp. 463-471. |
| Chen et al. Biomacromolecules. Feb. 2008: 9(2): 463-71. Epub Jan. 16. (Year: 2008). |
| OMG Borchers GMBH; “Low molecular weight methyl polysiloxane for improved leveling and anti-float properties in solvent based coatings systems. 100 % active ingredient” ; Aug. 28, 2009. |
| Yang et al. Biotechnol Lett. Jul. 2010: 32(7): 951-6. Epub Mar. 8, 2010 (Year: 2010). |
| OMG Borchers GMBH; “Low molecular weight methyl polysiloxane for improved leveling and anti-float properties in solvent based coatings systems. 100 % active” ; Jul. 1, 2014. |
| Final Office Action dated Apr. 27, 2015 for U.S. Appl. No. 14/166,376. |
| Non-Final Office Action dated Jan. 14, 2015 for U.S. Appl. No. 14/166,376. |
| Non-Final Office Action dated Sep. 25, 2015 from U.S. Appl. No. 14/643,445, filed Mar. 10, 2015. |
| Office Action Response filed Apr. 14, 2015 for U.S. Appl. No. 14/166,376. |
| Office Action Response filed Apr. 27, 2015 for U.S. Appl. No. 14/097,128. |
| Office Action Response filed Dec. 29, 2015 from U.S. Appl. No. 14/643,445, filed Mar. 10, 2015. |
| Rinkoo Devi Gupta, “Recent advances in enzyme promiscuity” , Sustain Chem Process, vol. 4, Issue 2 (Date: 2016). |
| Third-Party Submission Under 37 CFR 1.290 dated Aug. 13, 2018 filed in U.S. Appl. No. 15/790,846, filed Oct. 23, 2017. |
| Third-Party Submission Under 37 CFR 1.290 dated Jul. 25, 2018 filed in U.S. Appl. No. 15/810,700, filed Nov. 13, 2017. |
| Third-Party Submission Under 37 CFR 1.290 dated Jul. 25, 2018 filed in U.S. Appl. No. 15/810,713, filed Nov. 13, 2017. |
| Reactive Surfaces v. Toyota Motor Corporation, Case IPR2017-00572, Paper No. 42 (PTAB, Feb. 5, 2017). |
| Notice of Appeal and Pre-Brief Conference Request filed on Jun. 26, 2015 for U.S. Appl. No. 14/166,376. |
| Pre-Brief Appeal Conference Decision dated Jul. 21, 2015 for U.S. Appl. No. 14/166,376. |
| Notice of Allowance and Notice of Allowability dated Jul. 24, 2015 for U.S. Appl. No. 14/166,376. |
| Reactive Surfaces v. Toyota Motor Corporation, Case IPR2018-01194 filed Jun. 4, 2018, Petition for Inter Partes Review of U.S. Pat. No. 9, 193,873 B2 with Declaration and Resume of Dr. David Rozzell, Ph.D. |
| Amendment and RCE Response filed Aug. 26, 2015 for U.S. Appl. No. 14/097,128. |
| Rebuttal document produced during oral deposition of Douglas Lamb, Ph.D.; May 10, 2017. |
| Reply Declaration of Eric Ray; Nov. 6, 2017. |
| Reactive Surfaces v. Toyota Motor Corporation, Case IPR2019-00867, Petition for Inter Partes Review of U.S. Pat. No. 9,428,740 B2, PTAB (Mar. 21, 2019). |
| Recorded Assignment Documentation for U.S. Appl. No. 14/643,445, filed Mar. 10, 2015 (Exhibit 1003 from IPR2019-00867). |
| Declaration of Dr. David Rozzell, Ph.D. (Exhibit 1009 from IPR2019-00867)—May 14, 2018. |
| Notice of Allowance and Notice of Allowability dated Apr. 28, 2016 from U.S. Appl. No. 14/643,445, filed Mar. 10, 2015. |
| Deposition Transcript of Dr. Jonathan S. Dordick from IPR2016-01914 (Exhibit 1015 from IPR2019-00867)—Oct. 18, 2017. |
| A. Dorinson et al, “Refractive Indices and Densities of Normal Saturated Fatty Acids in the Liquid State” , J. Am. Chem. Soc., 1942, 64(12), pp. 2739-2741. |
| B.M. Craig, “Refractive Indices of Some Saturated and Monoethenoid Fatty Acids and Methyl Esters”, Canadian Journal of Chemistry, 1953, 31(5): pp. 499-504, https://doi.org/10.1139/v53-068. |
| Arthur and Elizabeth Rose, “The Condensed Chemical Dictionary (7th Ed.)” , New York: Reinhold Publishing Co., pp. 80, 104, 222-223, 545, 556, 644-645, 691, 704, 716, 887, 891 (1961. |
| Bernfield, P. And Wan, J., “Antigens and Enzymes Made Insoluble by Entrapping Them into Lattices of Synthetic Polymers”, Science 142 (3593), pp. 678-679 (1963. |
| E.A. Stein et al., “Alpha-Amylases as Calcium-Metalloenzymes. I. Preparation of Calcium-free Apoamylases by Chelation and Electrodialysis” , Biochemistry, vol. 3, No. 1, Jan. 1964, pp. 56-61. |
| B. Drozdowski et al.,. “Isopropyl Alcohol Extraction of Oil and Lipids in the Production of Fish Protein Concentrate from Herring”, Journal of the American Oil Chemists' Society, (Jul. 1969) vol. 46, pp. 371-376. |
| B. Scruton et al, “The deposition of fingerprint films” 1975 J. Phys. D: Appl PHys. 8 pp. 714-723. |
| G L Thomas and T E Reynoldson, “Some observations on fingerprint deposits” , 1975 J. Phys. D: Appl. Phys. vol. 8 (1975) pp. 724-729. |
| Fukui et al., “Application of Photo-Crosslinkable Resin to Immobilization of an Enzyme” , FEBS Letters, Jul. 1976, pp. 179-182, vol. 66, No. 2. |
| Robert D. Olsen, Sr., “Scott's Fingerprint Mechanics” Chapter III, “Latent Fingerprints and Crime Scene Procedures” , (1978) pp. 109-158. |
| Pollak et al., “Enzyme Immobilization by Condensation Copolymerization into Cross-Linked Polyacrylamide Gels”, J. Am. Chem. Soc. 1980, 102, pp. 6324-6336. |
| Takagi, Toshio, “Confirmation of Molecular Weight of Aspergillus oryzae a-Amylase Using the Low Angle Laser Light Scattering Technique in Combination with High Pressure Silica Gel Chromatography” , J. Biochem. vol. 89, No. 2, (1981), pp. 363-368. |
| K. Yokozeki et al., “Application of Immobilized Lipase to Regio-Specific Interesterification of Triglyceride in Organic Solvent” , European J Appl Microbiol Biotechnol (1982) 14:1-5. |
| Enzyme Nomenclature 1984, “Recommendations of the Nomenclature Committee of the International Union of Biochemistry on the Nomenclature and Classification of Enzyme-Catalysed Reactions” , Academic Press, New York (1984) pp. 270-279. |
| United States Department of Justice♯Federal Bureau of Investigation, “The Science ofFingerprints—Classification and Uses”, (Rev. 12-84), Chapter XIII “Latent Impressions” pp. 170-174 (1985). |
| Fukui et al., “[20] Entrapment of Biocatalysts with Photo-Cross-Linkable Resin Prepolymers and Urethane Resin Prepolymers” , Methods in Enzymology, vol. 135, 1987, pp. 230-252. |
| Fusee, Murray C., “[42] Industrial Production of L-Aspartic Acid Using Polyurethane-Immobilized Cells Containing Aspartase” , Methods in Enzymology, vol. 136, 1987, pp. 463-471. |
| G.J. Calton et al., “[45] Phenylalanine Production via Polyazetidine-Immobilized Escherichia coli: Optimization of Cell Loading” Methods in Enzymology, vol. 136, 1987, pp. 497-502. |
| J. David Rozzell, “Immobilized Aminotransferases for Amino Acid Production” , Methods in Enzymology, vol. 136, (1987) pp. 479-497. |
| Robert D. Olsen, Sr., “Chemical Dating Techniques for Latent Fingerprints: A Preliminary Report” , Identification News, (Feb. 1987) pp. 10-12. |
| David Rozzell and Fritz Wager (Eds), Biocatalytic Production of Amino Acids & Derivatives, Chapter 13 “Immobilized Enzymes: Techniques & Applications”, Hanser Publishers (1992), pp. 306-319. |
| M.S. Kunz et al., “Colloidal Gold Dispersions in Polymeric Matrices”, Journal of Colloid and Interface Science 156, pp. 240-249 (1993). |
| Kostadin Bobev, “Fingerprints and Factors Affecting Their Condition” , J. Forensic Ident. 176/45 (2) 1995, pp. 176-183. |
| Science News Staff, “Fleeting Fingerprints May Yield Powerful New Tools” , Apr. 15, 1997. |
| L.R. Murphy et al., “Research Paper Protein hydraftion and unfolding” , Folding & Design vol. 3, No. 2, 1998, pp. 105-118. |
| E. Roland Menzel, Fingerprint Detection With Lasers, Chapter 7 “Photoluminescence-Based Physical Treatments” Marcel Dekker, Inc. (1999) pp. 155-178. |
| Gary Mong et al., “The Chemistry of Latent Prints from Children and Adults” , The Chesapeake Examiner, Fall 1999, vol. 37, No. 2, pp. 4-6. |
| Deliang He et al., a-Amylase immobilized on bulk acoustic-wave sensor by UV-curing coating, Biochemical Engineering Journal 6 (2000) 7-11. |
| A. Gole et al., “Pepsin-Gold Colloid Conjugates: Preparation, Characterization, and Enzymatic Activity” , Langmuir 2001, 17, pp. 1674-1679. |
| K. Won et al., “Effects of Water and Silica Gel on Enzyme Agglomeration in Organic Solvents” , Biotechnol. Bioprocess Eng. 2001, vol. 6, No. 2, pp. 150-155. |
| R. Balasubramanian et al., “Extraction and Dispersion of Large Gold Nanoparticles in Nonpolar Solvents” , J. Dispersion Science and Technology, vol. 22, No. 5, pp. 485-489 (2001). |
| Ramotowski, R.S., in Advances in Fingerprint Technology, Chapter 3, Henry C Lee and R.E. Gaensslen, eds., CRC Press, Boca Raton, (2001) pp. 63-104. |
| Robert S. Ramotowski, Advances in Fingerprint Technology (2nd Ed.), Chapter 3, “Composition of Latent Print Residue” , In H.C. Lee and R.E. Gaensslen (Eds), Boca Raton: CRC Press, (2001) pp. 63-104. |
| Young Duk Kim et al., “Siloxane-Based Biocatalytic Films and Paints for Use as Reactive Coatings” , Biotechnology and Bioengineering, vol. 72, No. 4, Feb. 20, 2001, pp. 475-482. |
| A. Gole et al., “Studies on the formation of bioconjugates of Engoglucanase with colloidal gold” , Colloids and Surfaces B: Biointerfaces 25 (2002) pp. 129-138. |
| Edward Bartick et al., “Spectrochemical Analysis and Hyperspectral Imaging of Latent Fingerprints” , 16th Meeting of the International Association of Forensic Sciences, (2002) pp. 61-64. |
| Keiji G. Asano et al., “Chemical Composition of Fingerprints for Gender Determination” , J Forensic Sci, Jul. 2002, vol. 47, No. 4. |
| Product Sheet by Novozymes A/S for Termamyl 120L, Type L pp. 1:4-4:4 (2002). |
| C.P. Poole, Jr. et al., “Introduction to Nanotechnology” , John Wiley & Sons, 2003, Hoboken, NJ, Table 12.1 on p. 315. |
| Anil K. Jain et al., “Integrating Faces, Fingerprints, and Soft Biometric Traits for User Recognition” , Proceedings of 41 Biometric Authentication Workshop, LNCS 3087, pp. 259-269, Prague, May 2004. |
| Diane K. Williams et al., “Analysis of Latent Fingerprint Deposits by Infrared Microspectroscopy” , Applied 42 Spectroscopy, vol. 58, No. 3, (2004) pp. 313-316. |
| G. Muralikrishna et al., “Cereal a-amylases—an overview” , Carbohydrate Polymers 60 (2005) pp. 163-173. |
| Methods in Biotechnology, vol. 17, Microbial Enzymes and Biotransformations, Humana Press, Inc., Totowa, NJ, (2005), Scott J. Novick and J. David Rozzell, “Immobilization of Enzymes by Covalent Attachment”. |
| Kimone M. Antoine, “Chemical Differences are Observed in Children's Versus Adults' Latent Fingerprints as a Function of Time”, J Forensic Sci, Mar. 2010, vol. 55, No. 2. |
| S.M. Bleay et al, “Fingerprint Source Book: manual of development techniques”, London: Home Office—Centre for Applied Sciences and Technology. Chapter 2: Finger mark examination techniques within scope of ISO 17025, pp. 3-38 (2013) URL: http://www.gov.uk/government/publications/fingerprint-source-book. |
| Reactive Surfaces v. Toyota Motor Corporation, Case IPR2017-00572, Paper No. 42 (PTAB, Feb. 5, 2018). |
| T. Kent (Ed.), Manual of Fingerprint Development Techniques—A Guide to the Selection and Use of Processes for the Development of Latent Fingerprints, 2nd Ed 1998 (Revised Jan. 2001), Sandridge: Home Office Police Scientific Develpment Branch, Chapter 1 “Latent Fingerprints”, Sections 1.1, 1.2, 2.6 and “Visual Examination”. |
| Wang, P. et al., Enzyme Stabilization by Covalent Binding in Nanoporous Sol-Gel Glass for Nonaqueous Biocatalysis; Biotech. Bioeng. 2001, 74(3):249-255. |
| Kim Y. et al, Siloxane-based biocatalytic films and paints for use as reactive coatings, Biotechnology and Bioengineering 2001, 72(4), 475-482. |
| H.N. Fernley and P.G. Walker, “Studies on Alkaline Phosphatase: Inhibition by Phosphate Derivatives and the Substrate Specificity” Biochem. J. (1967) 104, 1011-1018. |
| J.M. Widholm et al., “Inhibition of Cultured Cell Growth by Tungstate and Molybdate” , Plant Cell Reports (1983) 2: 15-18, Springer-Verlag. |
| Annamaria Guagliardi et al., “Stability and activity of a thermostable malic enzyme in denaturants and water-miscible organic solvents” Eur. J. Biochem. 183, 25-30 (1989). |
| Joan L. Huber et al., “Inactiviation of Highly Activated Spinach Leaf Sucrose-Phosphate Synthase by Dephosphorylation” , Plant Physiol. (1991) 95, 291-297. |
| H. Domininghaus, “Plastics for Engineers: Materials, Properties, Applications” , 1993, p. 612, Carl Hanser. |
| David B. Volkin, Henryk Mach and C. Russell Middaugh, “Review: Degradative Covalent Reactions Important to Protein Stability”, Molecular Biotechnology 105, vol. 8, pp. 105-121 (1995). |
| K.J. Lewis, J.H. Aklian, A. Sharaby, J.D. Zook, “Quantitative methods of predicting relative effectiveness of corrosion inhibitive coatings” , Aircraft Engineering and Aerospace Technology, (1996) vol. 68 Issue: 3, pp. 12-22. |
| Dieter Stoye and Werner Freitag (Editors “Paints, Coatings and Solvents”, Second, Completely Revised Edition, “5. Paint Additives” , 1998, p. 170, Wiley VCH. |
| R. Lambourne and T.A. Strivens (Editors), “Paint and surface coatings—Theorgy and practice” second edition, “5.18 Ultraviolet absorbers” , 1999, pp. 195-196, William Andrew Publishing. |
| Johan Bieleman (Editor), “Additives for Coatings”, “8,2,3 Properties of Light Stabilizers”, 2000, pp. 279-280, Wiley VCH. |
| Travis J. O'Brien et al., Effects of hexavalent chromium on the survival and cell cycle distribution of DNA repair-deficient S. cerevisiae, DNA Repair 1 (2002) 617-627, Elsevier. |
| Muxin Liu, Michael A. Brook, Paul M. Zelisko and Amro N. Ragheb, “Chapter 11. Preparation and Applications of Silicone Emulsions Using Biopolymers”, Colloidal Biomolecules, Biomaterials, and Biomedical Applications (2003). |
| Manuela F. Frasco et al., “Mechanisms of cholinesterase inhibition by inorganic mercury”, FEBS Journal 274 (2007) 1849-1861. |
| Mansfeld et al. Biotechnol. Bioengineer. (2007) 97: 672-679 (Year: 2007). |
| Jose L. Muñoz-Muñoz et al., “Phenolic substrates and suicide inactivation of tyrosinase: kinetics and mechanism” , Biochem. J. (2008) 416, 431-440. |
| Roman Pichot, “Stability and Characterisation of Emulsions in the presence of Colloidal Particles and Surfactants” A thesis submitted to the University of Birmingham for the degree of Doctor of Philosophy, Nov. 2010. |
| “Emulsion Stability and Testing”, Technical Brief 2011 vol. 2, Particle Sciences, Inc. |
| Majumder et al. Int. J. Pharma Bio Sci. (2012) 3(1):610-627 (Year: 2012). |
| Ruby Ynalvez et al., “Mini-review: toxicity of mercury as a consequence of enzyme alternation” , Biometals (2016) 29: 781-788. |
| K.D. Ralston et al., “Electrochemical Evaluation of Constituent Intermetallics in Aluminum Alloy 2024-T3 Exposed to Aqueous Vanadate Inhibitors” , Journal of The Electrochemical Society, 156 (4) C135-C146 (2009). |
| S. Gourinath et al. “Mercury induced modifications in the stereochemistry of the active site through Cys-73 in a serine protease—Crystal structure of the complex of a partially modified proteinase K with mercury at 1.8 Å resolution”, Indian Journal of Biochemistry & Biophysics, vol. 38, Oct. 2001, pp. 298-302. |
| Defoamer Technologies Agitanò, Münzing, PCA Apr. 2012. |
| Solvent Miscibility Table / Solvent Polarity Chart (2013). |
| Reactive Surfaces v. Toyota Motor Corporation, Case IPR2016-01914, Paper No. 64 (PTAB, Mar. 1, 2018). |
| Reactive Surfaces v. Toyota Motor Corporation, Case IPR2016-01462, Paper No. 51 (PTAB, Jan. 12, 2018). |
| Masahiro Takagi et al.; Nucleotide Sequence and Promoter Region for the Neutral Protease Gene from Bacillus stearothermophilus; Journal of Bacteriology, Sep. 1985, pp. 824-831. |
| Jaroslava Turkov; Immobilization of Enzymes on Hydroxyalkyl Methacrylate Gels; Immobilization Techniques; Methods in Enzymology; (1976); 344: pp. 66-83. |
| Minoru Kumakura et al.; 201. Interaction of Enzyme with Polymer Matrix in Immobilized Enzymes; Helvetica Chimica Acta; vol. 66; Fasc. 7; (1983); pp. 2044-2048. |
| LT COL C. Carl Bostek, “Effective methods of in-line intravenous fluid warming at low to moderate infusion rates” Journal of the American Association of Nurse Anesthetists, vol. 60, No. 6, Dec. 1992. |
| Johanna Mansfeld et al.; Site-specific and random immobilization of thermolysin-like proteases reflected in the thermal inactivation kinetics; Biotechnol. Appl. Biochem. (2000); pp. 189-195. |
| Sookkheo et al., Protein Expression and Purification (2000) 20: 142-151. |
| Drevon, G. et al.; High-Activity Enzyme-Polyurethane Coatings, Biotechnology and Bioengineering, 79(7): 785-794, Sep. 30, 2002. |
| Drevon, Graldine F., “Enzyme Immobilization into Polymers and Coatings” , University of Pittsburgh School of Engineering Dissertation, Nov. 2002. |
| Geraldine F. Drevon et al.; High-Activity Enzyme-Polyurethane Coatings; (2002) Biotechnology and Bioengineering, vol. 70, No. 7, Inc. pp. 785-794. |
| Novick, S. et al.; Protein-containing hydrophobic coatings and films, Biomaterials, 23: 441-448, 2002. |
| Roberts, “Chemistry for peptide and protein PEGylation” , Advanced Drug Delivery Reviews, vol. 54, 2002, p. 459-476. |
| Kuniyo Inouye et al.; Engineering, expression, purification, and production of recombinant thermolysin; Biotechnology Annual Review; vol. 13; ISSN 1387-2656; pp. 43-64 (2007). |
| Mansfeld, “The Stability of Engineered Thermostable Neutral Proteases from Bacillus Stearothermophilus in Organic Solvents and Detergents” , Biotechnol. Bioeng. (2007) 97 (4): 672-679. |
| Mcdaniel, C.S. et al., “Biocatalytic paints and coatings,” ACS Symposium Series (2009), 1002 (Smart Coatings II), pp. 239-249. |
| Mcdaniel, Steve et al., “Functional Additives: A Platform for Revitalizing the Paint and Coatings Industry” , coatingsworld.com, Feb. 2010. |
| Mcdaniel, Steve, “Bioengineered Additives A Pipeline of Value Delivering Unique Functionality to Your Coating” , Coatings World, vol. 15, No. 5, coatingsworld.com, May 2010. |
| Mcdaniel, Steve, “Formulating with Bioengineered Additives: Enhancing the Performance and Functionality of Paints and Coatings”, coatingsworld.com, Mar. 2010. |
| U.S. Appl. No. 12/643,666, filed Dec. 21, 2009. |
| Ciba TINUVIN 328 LIght Stabiliser, Ciba Specialty Chemicals Inc., Coating Effects Segment, Edition: 9.12.97 Basle. |
| Ciba Tinuvin 1130, Ciba Specialty Chemicals Inc., Coating Effects Segment, Edition: 15.12.97 Basle. |
| “Printing & Packaging Industrial Coatings Technical Data Sheet Tinuvin 400” BASF The Chemical Company, Dec. 2010 Rev 1. |
| Number | Date | Country | |
|---|---|---|---|
| 20230374420 A1 | Nov 2023 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16900386 | Jun 2020 | US |
| Child | 18327433 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15810700 | Nov 2017 | US |
| Child | 16900386 | US | |
| Parent | 13567341 | Aug 2012 | US |
| Child | 15193242 | US | |
| Parent | 13229277 | Sep 2011 | US |
| Child | 14812087 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15193242 | Jun 2016 | US |
| Child | 15810700 | US | |
| Parent | 12820101 | Jun 2010 | US |
| Child | 13567341 | US | |
| Parent | 14812087 | Jul 2015 | US |
| Child | 15810700 | Nov 2017 | US |
